{"gene":"HIF1A","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1992,"finding":"A nuclear factor (HIF-1) is induced by hypoxia via de novo protein synthesis and binds to a site in the human erythropoietin gene enhancer required for transcriptional activation, establishing HIF-1 as a hypoxia-responsive transcriptional activator.","method":"DNase I footprinting, EMSA, reporter gene transfection, cycloheximide inhibition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical binding assay with mutagenesis, foundational paper with >2000 citations","pmids":["1448077"],"is_preprint":false},{"year":1993,"finding":"HIF-1 DNA-binding activity is induced by hypoxia in a wide variety of mammalian cell types (not only EPO-producing cells), establishing HIF-1 as a general mediator of transcriptional responses to hypoxia.","method":"EMSA, reporter gene transfection, mutagenesis across multiple cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple cell lines, reporter assays with mutagenesis, >1200 citations","pmids":["8387214"],"is_preprint":false},{"year":1994,"finding":"HIF-1 directly binds to HRE sequences in the promoters of glycolytic enzyme genes (aldolase A, PGK1, enolase 1, LDHA, PFKL) and activates their transcription under hypoxia, linking HIF-1 to metabolic reprogramming.","method":"EMSA with affinity-purified HIF-1, reporter gene transfection with HRE sequences, RNA induction assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct DNA binding demonstrated with purified protein plus functional reporter assays, >1400 citations","pmids":["8089148"],"is_preprint":false},{"year":1995,"finding":"HIF-1 is a heterodimer of two bHLH-PAS proteins: HIF-1α (most closely related to Drosophila Sim) and HIF-1β (ARNT). Both subunits are induced at 1% O₂ and decay upon reoxygenation.","method":"Protein purification, biochemical characterization, molecular cloning, RNA/protein level measurements under hypoxia","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — protein purification + cloning + functional characterization, >5000 citations","pmids":["7539918"],"is_preprint":false},{"year":1995,"finding":"HIF-1 purified as a heterodimer (~120 kDa HIF-1α and 91–94 kDa HIF-1β subunits); both subunits contact DNA directly; HIF-1 binds specifically to the wild-type EPO enhancer HIF-1 binding site.","method":"Affinity chromatography purification, UV cross-linking, glycerol gradient sedimentation, EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification with multiple orthogonal methods, >1600 citations","pmids":["7836384"],"is_preprint":false},{"year":1996,"finding":"HIF-1 directly activates VEGF transcription by binding to a hypoxia-response element (HRE) in the VEGF 5'-flanking region; dominant-negative HIF-1α abolishes hypoxic VEGF induction; HIF-1β (ARNT)-null cells fail to induce VEGF mRNA.","method":"Reporter gene assays, HRE mutagenesis, dominant-negative cotransfection, ARNT-null cell lines","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of HRE + dominant-negative + null cells, >3200 citations","pmids":["8756616"],"is_preprint":false},{"year":1998,"finding":"HIF-1α contains an oxygen-dependent degradation (ODD) domain (~200 aa in the central region) that controls its ubiquitin-proteasome degradation; deletion of the entire ODD yields a stable, functional HIF-1α under normoxia; ODD alone confers O₂-dependent instability when fused to a stable protein.","method":"Domain deletion mutagenesis, fusion-protein stability assays, heterodimerization and transactivation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with multiple functional readouts, >1700 citations","pmids":["9653127"],"is_preprint":false},{"year":1999,"finding":"pVHL targets HIF-α subunits for oxygen-dependent proteolysis: VHL-defective cells constitutively stabilize HIF-α; re-expression of pVHL restores O₂-dependent instability; pVHL and HIF-α co-immunoprecipitate and the interaction is iron-dependent.","method":"VHL re-expression in VHL-null cells, co-immunoprecipitation, iron chelation experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus genetic rescue in VHL-null cells, >4200 citations","pmids":["10353251"],"is_preprint":false},{"year":1999,"finding":"Hsp90 interacts with the bHLH-PAS domain of HIF-1α under normoxia but not hypoxia; Hsp90 is not co-translocated to the nucleus with HIF-1α; Hsp90 activity is required for HIF-1 activation (inhibited by geldanamycin).","method":"EGFP-HIF-1α co-immunoprecipitation in COS-7 cells, domain mapping, geldanamycin pharmacological inhibition","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with domain mapping and pharmacological validation, single lab","pmids":["10544245"],"is_preprint":false},{"year":2000,"finding":"pVHL, through its β-domain, directly binds HIF-α and targets it for ubiquitination in an α-domain-dependent manner, providing the first evidence that pVHL functions analogously to an F-box protein recruiting substrates to the ubiquitination machinery.","method":"Direct binding assays, ubiquitination assays, domain mutagenesis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 — direct binding plus ubiquitination reconstitution with domain mutagenesis, >1295 citations","pmids":["10878807"],"is_preprint":false},{"year":2001,"finding":"HIF-1α is targeted for VHL-mediated ubiquitylation through O₂-regulated hydroxylation of proline residue P564 by a HIF-α prolyl-hydroxylase (HIF-PH/PHD); the reaction requires dioxygen and Fe²⁺ as cofactors, identifying PHD as the direct cellular oxygen sensor.","method":"Peptide binding assays, site-directed mutagenesis (P564), mass spectrometry, in vitro hydroxylation with Fe²⁺/O₂","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis + biochemical reconstitution + MS, >4600 citations","pmids":["11292861"],"is_preprint":false},{"year":2001,"finding":"pVHL binds HIF-1α-derived peptide only when a conserved proline is hydroxylated; proline hydroxylation requires molecular O₂ and Fe²⁺, placing this modification as the key oxygen-sensing step in HIF-1α degradation.","method":"Peptide binding assay, site-directed mutagenesis, Fe²⁺/O₂ dependency experiments","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution with mutagenesis, >3900 citations","pmids":["11292862"],"is_preprint":false},{"year":2001,"finding":"FIH-1 binds both HIF-1α and pVHL; FIH-1 inhibits HIF-1α transactivation function; VHL also acts as a transcriptional corepressor by recruiting histone deacetylases to inhibit HIF-1α transactivation independently of protein degradation.","method":"Yeast two-hybrid, co-immunoprecipitation, reporter assays, HDAC recruitment assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — multiple interaction methods plus functional reporter assays, >1173 citations","pmids":["11641274"],"is_preprint":false},{"year":2001,"finding":"Jab1 (COP9 signalosome subunit 5) directly interacts with HIF-1α, enhances HIF-1 transcriptional activity, increases HIF-1α protein stability, and interferes with p53–HIF-1α binding in a Jab1-dependent manner.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by GST pull-down and co-IP with functional validation, single lab","pmids":["11707426"],"is_preprint":false},{"year":2001,"finding":"A conserved family of HIF prolyl-hydroxylase (HPH/PHD) enzymes hydroxylates the ODD proline of HIF-1α; forced HIF-1α expression under normoxia is attenuated by HPH co-expression; RNAi knockdown of HPH in Drosophila cells elevates a hypoxia-inducible gene under normoxia.","method":"Sequence homology, co-expression normoxic stabilization assay, Drosophila cell RNAi","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — gain-of-function + RNAi loss-of-function in two systems, >2100 citations","pmids":["11598268"],"is_preprint":false},{"year":2002,"finding":"FIH-1 is an asparaginyl hydroxylase (Fe[II]-dependent, O₂-dependent dioxygenase) that hydroxylates a conserved asparagine in the C-terminal transactivation domain (CAD) of HIF-1α, blocking p300/CBP coactivator recruitment under normoxia.","method":"In vitro hydroxylation assay, mass spectrometry, Asn→Ala mutagenesis, p300 interaction assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — enzymatic reconstitution with MS identification and mutagenesis, >1253 citations","pmids":["12080085"],"is_preprint":false},{"year":2002,"finding":"Hypoxic induction of the HIF CAD requires abrogation of asparagine hydroxylation, which in normoxia prevents p300 coactivator interaction; Asn→Ala substitution yields constitutive p300 interaction and strong transcriptional activity; full HIF induction requires abrogation of both Pro and Asn hydroxylation.","method":"Dioxygenase inhibitors, Asn mutagenesis, p300 interaction assays, transcriptional reporter assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis + pharmacological inhibition + coactivator binding reconstitution, >1247 citations","pmids":["11823643"],"is_preprint":false},{"year":2002,"finding":"mTOR signaling promotes HIF-1α stabilization and HIF-1 transactivation; rapamycin inhibits hypoxia- and CoCl₂-induced HIF-1α accumulation; the ODD domain is the critical target of the rapamycin-sensitive mTOR pathway for HIF-1α stabilization.","method":"Rapamycin pharmacological inhibition, wild-type/rapamycin-resistant mTOR transfection, GAL4-HIF-1α domain mapping, reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — gain/loss-of-function with domain mapping and pharmacological confirmation, >1012 citations","pmids":["12242281"],"is_preprint":false},{"year":2002,"finding":"Calcium/calmodulin signaling and ERK pathway activation contribute to HIF-1 transcriptional activity under hypoxia; ionomycin additively activates HIF-1 without affecting HIF-1α protein level; calmodulin dominant-negative or BAPTA (Ca²⁺ chelator) inhibits hypoxia-induced HIF-1 activation; PD98059 (MEK inhibitor) blocks HIF-1 activation, placing Ca²⁺/calmodulin upstream of ERK.","method":"Pharmacological inhibitors, dominant-negative calmodulin, intracellular Ca²⁺ chelation, reporter assays","journal":"Annals of the New York Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological tools with dominant-negative approach, single lab","pmids":["12485909"],"is_preprint":false},{"year":2003,"finding":"PHD2 is the key oxygen sensor that sets low steady-state HIF-1α levels in normoxia; siRNA silencing of PHD2 alone is sufficient to stabilize and activate HIF-1α in all human cells tested under normoxia; silencing PHD1 or PHD3 has no effect on HIF-1α stability.","method":"siRNA knockdown of PHD1, PHD2, PHD3 individually in multiple human cell lines, HIF-1α stability and transcriptional activity assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — systematic RNAi with multiple cell lines and functional readouts, >1137 citations","pmids":["12912907"],"is_preprint":false},{"year":2003,"finding":"HIF-1α (not HIF-2α) is specifically required for glycolytic gene expression; HIF-2α can regulate a subset of broadly expressed hypoxia-inducible genes, demonstrating distinct non-redundant transcriptional programs for the two HIF-α paralogs.","method":"DNA microarray analysis of HIF-1α−/− cells, tetracycline-regulated stabilized HIF-1α or HIF-2α expression in HEK293 cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide comparison using isogenic cell lines with controlled expression, >1167 citations","pmids":["14645546"],"is_preprint":false},{"year":2005,"finding":"Succinate accumulation from SDH inhibition inhibits HIF-α prolyl hydroxylases in the cytosol, leading to HIF-1α stabilization and activation, thus linking mitochondrial TCA cycle dysfunction to HIF-1 oncogenic signaling.","method":"SDH inhibition/knockdown, prolyl hydroxylase activity assay with succinate, HIF-1α stability assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay demonstrating PHD inhibition by succinate plus cellular validation, >1721 citations","pmids":["15652751"],"is_preprint":false},{"year":2005,"finding":"HIF-1α promotes genetic instability by transcriptionally repressing MSH2 and MSH6 (MutSα mismatch repair complex) through displacing Myc from Sp1 binding sites at their promoters, in a p53-dependent manner.","method":"Reporter assays, chromatin immunoprecipitation, siRNA knockdown, co-immunoprecipitation, clinical specimen correlation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP, reporter assays, siRNA knockdown, multiple orthogonal methods, replicated in clinical specimens","pmids":["15780936"],"is_preprint":false},{"year":2007,"finding":"RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1α and promotes O₂/PHD/VHL-independent proteasomal degradation of HIF-1α by recruiting Elongin-C/B E3 ubiquitin ligase; RACK1 is required for HSP90 inhibitor-induced HIF-1α degradation.","method":"Co-immunoprecipitation, domain mapping, ubiquitination assays, RACK1 siRNA knockdown","journal":"Cell cycle","confidence":"High","confidence_rationale":"Tier 2 — domain-specific competition assay, ubiquitination reconstitution, RNAi validation, replicated in multiple contexts","pmids":["17361105"],"is_preprint":false},{"year":2007,"finding":"MgcRacGAP directly binds HIF-1α (verified in vitro and in vivo); MgcRacGAP overexpression inhibits HIF-1α transcriptional activity without affecting HIF-1α protein levels or subcellular localization; inhibition depends on the MgcRacGAP domain that interacts with HIF-1α.","method":"Yeast two-hybrid, in vitro pull-down, co-immunoprecipitation in mammalian cells, reporter assays, domain mutagenesis","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast 2-hybrid confirmed by pull-down and co-IP with functional assay, single lab","pmids":["17982282"],"is_preprint":false},{"year":2007,"finding":"HIF-1 regulates COX4 subunit composition in mammalian cells under hypoxia: HIF-1 activates transcription of COX4-2 and LON (a mitochondrial protease that degrades COX4-1), switching COX subunit composition to optimize respiratory efficiency at low O₂.","method":"ChIP, reporter assays, siRNA knockdown, oxygen consumption/ROS/ATP measurements, in vivo mouse model","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — ChIP + reporter + functional metabolic assays + in vivo validation, >996 citations","pmids":["17418790"],"is_preprint":false},{"year":2008,"finding":"HIF-1 directly binds the HRE in the TWIST proximal promoter to transcriptionally activate TWIST, thereby promoting epithelial-mesenchymal transition (EMT) and cancer metastasis; siRNA knockdown of TWIST reverses HIF-1α-driven EMT.","method":"ChIP, reporter assays, siRNA knockdown, EMT/invasion assays, clinical specimen analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP + reporter + siRNA rescue experiments, >1129 citations","pmids":["18297062"],"is_preprint":false},{"year":2008,"finding":"HIF1 transcription factor is activated by mechanical wounding of keratinocytes (via PI3K pathway, independently of O₂), and directly regulates laminin-332 (laminα3 chain promoter) expression to promote keratinocyte migration and wound re-epithelialization.","method":"HIF-1α protein stabilization assays, PI3K inhibition, siRNA knockdown of HIF-1α, reporter assay of laminin α3 promoter, scratch wound assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — reporter + siRNA knockdown + functional wound assay, single lab","pmids":["18713836"],"is_preprint":false},{"year":2009,"finding":"Acriflavine directly binds HIF-1α and HIF-2α and inhibits HIF-1 dimerization and transcriptional activity; this small molecule prevents tumor growth and vascularization in prostate cancer xenografts.","method":"Cell-based reporter screening, direct binding assay, dimerization assay, xenograft tumor models","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct binding + functional dimerization assay + in vivo xenograft, multiple orthogonal methods","pmids":["19805192"],"is_preprint":false},{"year":2009,"finding":"TNFα enhances HIF-1α protein expression (not mRNA) through IKKβ in breast cancer cells; IKKβ stable overexpression increases HIF-1α protein; IKKβ siRNA depletion or pharmacological inhibition (Bay 11-7082) reduces TNFα-induced HIF-1α; IKKβ-knockout MEFs show reduced VEGF expression.","method":"Western blot, siRNA/shRNA knockdown, IKKβ stable overexpression, pharmacological IKKβ inhibitor, IKKβ-null MEFs","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genetic and pharmacological approaches, single lab","pmids":["19766100"],"is_preprint":false},{"year":2011,"finding":"PKM2 directly interacts with HIF-1α and functions as a transcriptional coactivator, enhancing HIF-1 target gene transactivation by promoting p300 recruitment to HREs; PHD3 hydroxylates PKM2 at P403/P408, enhancing PKM2–HIF-1α interaction and coactivator function; this creates a positive feedback loop driving glucose metabolism reprogramming in cancer cells.","method":"Co-immunoprecipitation, ChIP, mass spectrometry (hydroxylation), anti-hydroxyproline antibody, PHD3 knockdown, metabolic assays (glucose uptake, lactate, O₂ consumption)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — co-IP + ChIP + MS identification of modification + functional metabolic assays, >1209 citations","pmids":["21620138"],"is_preprint":false},{"year":2011,"finding":"HIF-1 directly activates RORγt transcription and forms a tertiary complex with RORγt and p300 at the IL-17 promoter to drive TH17 differentiation; concurrently HIF-1 binds Foxp3 and targets it for proteasomal degradation, attenuating Treg development; this occurs under both normoxic and hypoxic conditions.","method":"ChIP, reporter assays, co-immunoprecipitation, proteasome inhibition, HIF-1α conditional knockout mice (T cell-specific), EAE model","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — ChIP + co-IP + conditional KO in vivo model, multiple orthogonal methods, >1335 citations","pmids":["21871655"],"is_preprint":false},{"year":2012,"finding":"HIF1A directly binds HRE elements in the WASF3 (WAVE3) gene promoter (demonstrated by ChIP) and activates its transcription under hypoxia, promoting cancer cell motility and invasion; WASF3 knockdown abrogates the hypoxic migratory response.","method":"ChIP, luciferase reporter assays, siRNA knockdown of WASF3, scratch wound migration assay","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + reporter + functional migration assay, single lab","pmids":["22581642"],"is_preprint":false},{"year":2015,"finding":"Microbiota-derived butyrate drives O₂ consumption by intestinal epithelial cells, stabilizing HIF-1 and enhancing barrier function; antibiotic depletion of microbiota reduces colonic butyrate and HIF expression; butyrate effects on barrier function are lost in HIF-null cells, linking butyrate metabolism to HIF-1 stabilization.","method":"Antibiotic microbiota depletion, butyrate supplementation, germ-free mice, HIF-null cells, O₂ sensing dye assays","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models (KO, germ-free, antibiotic) with mechanistic validation, >1288 citations","pmids":["25865369"],"is_preprint":false},{"year":2016,"finding":"TIP60 (KAT5) histone acetyltransferase complex is a conserved coactivator of HIF1: HIF1A interacts with and recruits TIP60 to chromatin; TIP60 is required for HIF1A-dependent chromatin modification and RNA Pol II activation at HREs but not for HIF1A binding to target genes.","method":"Co-immunoprecipitation, ChIP-seq, genetic knockdown in Drosophila and human colorectal cancer cells, RNA Pol II ChIP","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — co-IP + ChIP-seq + genetic loss-of-function in two organisms, multiple orthogonal methods","pmids":["27320910"],"is_preprint":false},{"year":2017,"finding":"KDM4A histone demethylase controls HIF-1α levels by removing the repressive H3K9me3 mark at the HIF1A locus; KDM4A depletion or inactivation leads to H3K9me3 accumulation at the HIF1A gene, reducing HIF-1α mRNA and protein, and decreasing hypoxic tumor-aggressive phenotypes.","method":"KDM4A siRNA knockdown, ChIP (H3K9me3 at HIF1A locus), RT-qPCR, HIF-1α protein/mRNA levels, invasion/migration assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP at specific locus + functional knockdown, single lab","pmids":["28894274"],"is_preprint":false},{"year":2018,"finding":"HIF1 binds to the PKM gene by chromatin immunoprecipitation and mediates an isoform switch from PKM1 to PKM2 after myocardial infarction, with coordinated upregulation of associated splicing factors (hnRNPA1, hnRNPA2B1, Ptbp1).","method":"Chromatin immunoprecipitation (ChIP) of HIF1 at PKM locus, RNA-seq, qRT-PCR, pyruvate kinase activity assays","journal":"Physiological genomics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with functional assays, single lab","pmids":["29652636"],"is_preprint":false},{"year":2019,"finding":"HIF-1α transcriptionally upregulates p53 by binding to five response elements in the p53 promoter under hypoxia; this HIF-1α-induced p53 is transcriptionally inactive but acts as a chaperone protein for HIF-1α, stabilizing its binding to downstream DNA response elements and increasing HIF-1 target gene synthesis.","method":"Reporter assays, ChIP, Co-immunoprecipitation, siRNA knockdown of HIF-1α, normoxia/hypoxia comparison","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + reporter + co-IP with functional gene expression readout, single lab","pmids":["31538203"],"is_preprint":false},{"year":2019,"finding":"HIF1A and NFAT5 coordinately boost antibacterial defense in macrophages under high-Na⁺ conditions: HIF1A-dependent autophagy induction and NFAT5-dependent autolysosomal targeting of intracellular E. coli are both required; this defense is independent of NOS2 and phagocyte oxidase.","method":"HIF1A siRNA/genetic knockdown, NFAT5 knockdown, autophagy flux assays, bacterial CFU assays, GSEA of transcriptome","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockdown of both factors with functional bacterial killing assay, single lab","pmids":["30982460"],"is_preprint":false},{"year":2020,"finding":"HIF1a in oligodendrocyte progenitor cells (OPCs) activates non-canonical target genes (including Ascl2, Dlx3) through interaction with the OPC-specific transcription factor OLIG2; these non-canonical targets suppress Sox10 and block OPC differentiation into oligodendrocytes; MEK/ERK inhibition restores Sox10 expression without affecting canonical HIF1a activity.","method":"ChIP-seq in OPCs, OLIG2 co-IP, Ascl2/Dlx3 overexpression, Sox10 reporter assays, MEK/ERK inhibitor rescue, human oligocortical spheroids","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq + co-IP + genetic gain-of-function + pharmacological rescue in human organoids, multiple orthogonal methods","pmids":["33091368"],"is_preprint":false},{"year":2021,"finding":"HIF-1α in cardiac fibroblasts (CFs) suppresses mitochondrial ROS to prevent excessive post-ischemic CF proliferation and scarring; CF-specific Hif-1a deletion increases mitochondrial ROS, excessive CF proliferation, and contractile dysfunction after MI; the mitochondrial-targeted antioxidant MitoTEMPO rescues Hif-1a mutant phenotypes.","method":"CF-specific Hif-1a knockout mice, MI model, scRNA-seq, 3D cardiac microtissues, MitoParaquat/MitoTEMPO pharmacological manipulation, ROS measurements","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with multiple functional readouts + pharmacological rescue + 3D model, single lab but multiple orthogonal methods","pmids":["34762860"],"is_preprint":false},{"year":2021,"finding":"m6A modification of Hif1a mRNA by FTO deficiency increases Hif1a mRNA translation via YTHDC2 recognition, elevating HIF1A protein; HIF1A then activates thermogenic gene transcription (Ppargc1a, Prdm16, Pparg), promoting white-to-beige adipocyte browning.","method":"FTO adipose-specific knockout mice, m6A-seq, RIP for YTHDC2, Hif1a KO rescue experiments, thermogenic gene expression, UCP1 assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO + m6A-seq + RIP + HIF1A KO epistasis, multiple orthogonal methods","pmids":["34569703"],"is_preprint":false},{"year":2022,"finding":"PADI4 directly interacts with and citrullinates HIF-1α at R698; this citrullination blocks VHL binding and prevents HIF-1α ubiquitination and proteasomal degradation, stabilizing HIF-1α; the PADI4 antagonist dihydroergotamine mesylate suppresses tumor progression.","method":"Co-immunoprecipitation, in vitro citrullination assay, mass spectrometry identification of citrullinated R698, VHL binding assay, ubiquitination assay, PADI4 inhibitor treatment","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution + MS identification of PTM + mechanistic interaction assays + in vivo tumor model","pmids":["39227578"],"is_preprint":false},{"year":2022,"finding":"Intermittent (rapid/cyclic) hypoxia increases HIF-1α protein via a distinct pathway involving KDM4A/KDM4B/KDM4C histone demethylases: intermittent hypoxia increases KDM4 activity, reduces H3K9me3 at the HIF1A locus, and increases HIF1A mRNA; this contrasts with chronic hypoxia, which decreases KDM4 activity and increases H3K9me3 globally and at the HIF1A locus.","method":"H3K9me3 ChIP at HIF1A locus, KDM4 activity assays, qRT-PCR, siRNA knockdown, comparison of intermittent vs chronic hypoxia protocols","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + KDM4 activity assay + siRNA, single lab but orthogonal methods","pmids":["36174675"],"is_preprint":false},{"year":2022,"finding":"STAT1 is a transcriptional suppressor of HIF1A: ATG7 deficiency upregulates STAT1 via an autophagy-independent pathway (through increased ZNF148 nuclear translocation), increased STAT1 binding to HIF1A promoter, and suppressed HIF1A expression, thereby impairing ischemia-induced angiogenesis.","method":"EC-specific Atg7 KO mice, ChIP (STAT1 at HIF1A promoter), co-immunoprecipitation (ATG7-ZNF148), HIF1A overexpression rescue, fludarabine STAT1 inhibition","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — conditional KO + ChIP + co-IP + genetic rescue + pharmacological validation in vivo","pmids":["36300763"],"is_preprint":false},{"year":2023,"finding":"USP51 deubiquitinase directly binds Elongin C (ELOC) and forms a complex with the VHL E3 ligase to deubiquitinate HIF1A, stabilizing it; HIF1A in turn transcriptionally upregulates USP51, forming a positive feedback loop; SENP1-mediated deSUMOylation of ELOC at K32 promotes USP51–ELOC interaction and HIF1A stabilization.","method":"Co-immunoprecipitation (USP51/VHL/ELOC complex), ubiquitination assay, ChIP (HIF1A binding to USP51 promoter), SUMOylation site mutagenesis (ELOC K32), in vitro deubiquitination assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 — deubiquitination reconstitution + complex co-IP + ChIP + mutagenesis of PTM site, multiple orthogonal methods","pmids":["37816999"],"is_preprint":false},{"year":2023,"finding":"BAP1 deubiquitylase binds HIF-1α (through its C-terminal domain residues I675, F678, I679, L691), deubiquitylates it, and stabilizes HIF-1α during hypoxia; BAP1 mutations abolishing this interaction reduce nuclear HIF-1α in mesothelioma biopsies and primary cells.","method":"Co-immunoprecipitation, computational modeling of binding interface, BAP1 mutagenesis (I675A/F678A/I679A/L691A), siRNA BAP1 knockdown, HIF-1α protein level assays in hypoxia","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct binding + mutagenesis + deubiquitylation assay + clinical specimen validation","pmids":["36656861"],"is_preprint":false}],"current_model":"HIF-1α is an O₂-regulated bHLH-PAS transcription factor that, under normoxia, is constitutively hydroxylated on Pro402/Pro564 by PHD2 (and related PHDs), enabling pVHL-mediated ubiquitination and proteasomal degradation, while asparagine-803 hydroxylation by FIH-1 blocks p300/CBP coactivator recruitment; under hypoxia both hydroxylation events are suppressed, allowing HIF-1α to heterodimerize with HIF-1β (ARNT), recruit coactivators including p300, TIP60, and PKM2, and directly bind hypoxia-response elements to transcriptionally activate hundreds of target genes controlling glycolysis, VEGF-driven angiogenesis, TWIST-mediated EMT, mitochondrial COX subunit switching, and immune cell fate; HIF-1α stability is additionally regulated by O₂-independent mechanisms including RACK1-mediated and HSP90-opposed ubiquitination, deubiquitination by BAP1 and USP51, citrullination at R698 by PADI4 (blocking VHL binding), mTOR-stimulated stabilization, and KDM4A/H3K9me3-mediated transcriptional control of the HIF1A locus."},"narrative":{"teleology":[{"year":1992,"claim":"Identification of a hypoxia-inducible nuclear factor (HIF-1) that binds the erythropoietin enhancer established the existence of a dedicated transcriptional oxygen-sensing pathway.","evidence":"DNase I footprinting and EMSA with cycloheximide block in Hep3B cells","pmids":["1448077"],"confidence":"High","gaps":["Identity of HIF-1 subunits unknown","Mechanism of O₂-dependent induction undefined","Generality beyond EPO gene not tested"]},{"year":1995,"claim":"Purification and cloning of HIF-1 as a bHLH-PAS heterodimer of HIF-1α and ARNT (HIF-1β) resolved its molecular architecture and showed both subunits contact DNA, while parallel work established HIF-1 as a general hypoxia mediator across cell types activating glycolytic and VEGF genes.","evidence":"Protein purification, UV cross-linking, cloning, EMSA/reporter assays in multiple cell lines and HRE mutagenesis","pmids":["7539918","7836384","8387214","8089148","8756616"],"confidence":"High","gaps":["Mechanism of O₂-dependent protein instability unknown","No post-translational modification identified","Coactivator recruitment mechanism undefined"]},{"year":1998,"claim":"Mapping the oxygen-dependent degradation (ODD) domain showed that a ~200 aa central region is both necessary and sufficient for O₂-regulated proteasomal degradation, narrowing the search for the oxygen-sensing modification.","evidence":"Systematic domain deletion and fusion-protein stability assays under normoxia/hypoxia","pmids":["9653127"],"confidence":"High","gaps":["Identity of the E3 ligase targeting the ODD unknown","Nature of the O₂-dependent modification undefined"]},{"year":1999,"claim":"Discovery that pVHL targets HIF-1α for O₂-dependent proteolysis provided the E3 ligase link, while HSP90 was identified as a normoxic chaperone of the bHLH-PAS domain required for HIF-1 competence.","evidence":"VHL re-expression rescue in VHL-null cells, co-IP, iron chelation; EGFP-HIF-1α co-IP and geldanamycin inhibition","pmids":["10353251","10544245"],"confidence":"High","gaps":["Molecular basis of O₂-dependent VHL–HIF-1α binding unknown","Nature of the iron-dependent signal unresolved"]},{"year":2001,"claim":"The oxygen-sensing mechanism was resolved: prolyl hydroxylases (PHD/HPH) hydroxylate Pro564 (and Pro402) using O₂ and Fe²⁺ as cofactors, creating the pVHL-binding epitope; simultaneously FIH-1 was identified as a VHL-interacting protein that represses HIF-1α transactivation.","evidence":"Peptide binding assays, site-directed mutagenesis, mass spectrometry, in vitro hydroxylation reconstitution, RNAi in Drosophila, yeast two-hybrid and reporter assays for FIH-1","pmids":["11292861","11292862","11598268","11707426","10878807","11641274"],"confidence":"High","gaps":["Whether FIH-1 is also a hydroxylase not yet shown","Relative contributions of PHD1/2/3 unresolved","No structural model of hydroxylated HIF–VHL complex"]},{"year":2002,"claim":"FIH-1 was shown to be an asparaginyl hydroxylase modifying Asn803, which blocks p300/CBP recruitment; full HIF-1 activation requires abrogation of both prolyl and asparaginyl hydroxylation, establishing a dual oxygen-sensing checkpoint; mTOR was identified as an O₂-independent positive regulator acting through the ODD domain.","evidence":"In vitro hydroxylation with MS, Asn→Ala mutagenesis, p300 interaction assays; rapamycin inhibition with rapamycin-resistant mTOR rescue and ODD domain mapping","pmids":["12080085","11823643","12242281"],"confidence":"High","gaps":["Structural basis of Asn-OH blocking p300 unknown","mTOR mechanism on ODD not molecularly defined","In vivo validation of dual checkpoint limited"]},{"year":2003,"claim":"PHD2 was identified as the critical prolyl hydroxylase setting normoxic HIF-1α levels, and HIF-1α was shown to specifically govern glycolytic gene expression (distinct from HIF-2α), establishing non-redundant target gene programs.","evidence":"Systematic siRNA knockdown of PHD1/2/3 in multiple human cell lines; DNA microarray comparison of HIF-1α−/− cells with regulated HIF-1α or HIF-2α re-expression","pmids":["12912907","14645546"],"confidence":"High","gaps":["Whether PHD2 dominance holds in all tissues unknown","Chromatin-level basis of target gene selectivity unresolved"]},{"year":2005,"claim":"Succinate accumulation from SDH deficiency was shown to inhibit PHDs and stabilize HIF-1α, linking TCA cycle mutations to pseudo-hypoxic oncogenic signaling.","evidence":"SDH knockdown/inhibition with direct PHD activity assays and HIF-1α stability measurements","pmids":["15652751"],"confidence":"High","gaps":["Whether fumarate acts similarly not yet addressed","Quantitative kinetic parameters of metabolite-PHD inhibition undefined"]},{"year":2007,"claim":"RACK1 was identified as a VHL/PHD-independent degradation pathway for HIF-1α, competing with HSP90 for the PAS-A domain and recruiting Elongin-C/B; separately, HIF-1 was shown to switch mitochondrial COX subunit composition (COX4-1→COX4-2) via LON protease induction, optimizing respiration at low O₂.","evidence":"RACK1 co-IP, domain competition, ubiquitination assay, siRNA; COX subunit ChIP, reporter, siRNA, metabolic flux and in vivo mouse model","pmids":["17361105","17418790"],"confidence":"High","gaps":["Physiological contexts where RACK1 pathway dominates unclear","Structural basis of RACK1–HSP90 competition undefined"]},{"year":2008,"claim":"HIF-1α was shown to directly transactivate TWIST to drive EMT and metastasis, and to respond to non-hypoxic stimuli (mechanical wounding via PI3K), broadening the functional scope beyond classical hypoxia targets.","evidence":"ChIP at TWIST promoter, siRNA rescue of EMT; PI3K inhibition and scratch-wound assay with laminin-332 reporter","pmids":["18297062","18713836"],"confidence":"High","gaps":["Whether TWIST is a direct or cooperative HIF-1α target in all cancer contexts unknown","PI3K-HIF-1α stabilization mechanism not molecularly defined"]},{"year":2011,"claim":"Two major coactivator mechanisms were defined: PKM2 (itself hydroxylated by PHD3) acts as a HIF-1α coactivator enhancing p300 recruitment in a metabolic positive-feedback loop; HIF-1α drives TH17/Treg balance by activating RORγt while targeting Foxp3 for degradation, establishing HIF-1α as a lymphocyte fate regulator.","evidence":"PKM2 co-IP, ChIP, MS of hydroxylation, metabolic assays; T-cell-specific HIF-1α conditional KO mice, co-IP with Foxp3, EAE model","pmids":["21620138","21871655"],"confidence":"High","gaps":["Whether PKM2-HIF-1α axis operates in non-cancer tissues unclear","Mechanism of HIF-1α-mediated Foxp3 proteasomal targeting not fully defined"]},{"year":2016,"claim":"TIP60 (KAT5) was identified as a conserved HIF-1α coactivator required for chromatin modification and RNA Pol II activation at HREs but dispensable for HIF-1α DNA binding, separating chromatin remodeling from target-site recognition.","evidence":"Co-IP, ChIP-seq, genetic knockdown in Drosophila and human cells, RNA Pol II ChIP","pmids":["27320910"],"confidence":"High","gaps":["Whether TIP60 is required at all HIF-1 target genes or a subset unknown","Relationship between TIP60 and p300 coactivator functions not delineated"]},{"year":2020,"claim":"HIF-1α was shown to activate non-canonical gene programs through interaction with lineage-specific transcription factors (OLIG2 in OPCs), suppressing Sox10 and blocking oligodendrocyte differentiation; MEK/ERK inhibition selectively reversed this non-canonical activity.","evidence":"ChIP-seq in OPCs, OLIG2 co-IP, gain-of-function, MEK inhibitor rescue, human oligocortical spheroids","pmids":["33091368"],"confidence":"High","gaps":["Whether other lineage-specific TF partners redirect HIF-1α in additional cell types is unexplored","Structural basis of HIF-1α–OLIG2 interaction unknown"]},{"year":2022,"claim":"O₂-independent regulatory inputs to HIF-1α were expanded: PADI4 citrullinates R698 to block VHL binding, KDM4A demethylates H3K9me3 at the HIF1A locus to control its transcription (with distinct dynamics under intermittent vs. chronic hypoxia), and STAT1 acts as a transcriptional repressor of HIF1A downstream of ATG7/ZNF148.","evidence":"In vitro citrullination with MS, VHL binding/ubiquitination assays; H3K9me3 ChIP at HIF1A locus under intermittent/chronic hypoxia; EC-specific Atg7 KO with STAT1 ChIP at HIF1A promoter and rescue experiments","pmids":["39227578","36174675","28894274","36300763"],"confidence":"High","gaps":["Physiological triggers of PADI4-mediated citrullination of HIF-1α in vivo unknown","How intermittent vs. chronic hypoxia differentially controls KDM4 activity mechanistically unclear"]},{"year":2023,"claim":"Two deubiquitinases were identified as direct HIF-1α stabilizers: BAP1 binds HIF-1α through defined C-terminal residues and its loss reduces nuclear HIF-1α in mesothelioma; USP51 forms a complex with VHL/Elongin-C to deubiquitinate HIF-1α, with SENP1-mediated deSUMOylation of Elongin-C promoting this interaction, creating a transcriptional positive-feedback loop.","evidence":"Co-IP, mutagenesis of BAP1 binding interface, deubiquitination assays, clinical mesothelioma validation; USP51–VHL–ELOC complex co-IP, ChIP of HIF-1α at USP51 promoter, ELOC K32 SUMOylation mutagenesis","pmids":["36656861","37816999"],"confidence":"High","gaps":["Relative quantitative contributions of BAP1 vs. USP51 to HIF-1α pool in different tissues unknown","Whether BAP1 deubiquitination opposes VHL-specific ubiquitin chains or broader ubiquitin conjugates not defined"]},{"year":null,"claim":"Key unresolved questions include: how lineage-specific transcription factor partnerships (beyond OLIG2 and RORγt) redirect HIF-1α target gene selection genome-wide; the structural basis of the RACK1–HSP90 competition at the PAS-A domain; quantitative integration of the multiple PHD-independent stabilization inputs (PADI4, BAP1, USP51, RACK1, mTOR) in physiological contexts; and whether intermittent versus chronic hypoxia engage fundamentally different HIF-1α regulatory circuits in vivo.","evidence":"","pmids":[],"confidence":"High","gaps":["Genome-wide chromatin accessibility basis for context-dependent HIF-1α target selection unknown","No integrated quantitative model of competing stabilization/degradation signals","In vivo validation of many O₂-independent regulatory mechanisms limited to single tissue models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,3,5,20,26,31,34,39]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,4,5,32,34]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3,46]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[34,39]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,5,20,26,31,34,39]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[6,10,11,14,19,21,33]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,20,25,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,29,44]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[31,38]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7,9,10,42,45,46]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,7,23]}],"complexes":["HIF-1 (HIF-1α/ARNT heterodimer)","VHL-Elongin-C/B E3 ligase complex"],"partners":["ARNT","VHL","EGLN1","HIF1AN","EP300","KAT5","PKM","BAP1"],"other_free_text":[]},"mechanistic_narrative":"HIF-1α is the oxygen-regulated α subunit of the HIF-1 heterodimeric transcription factor that serves as a master regulator of cellular adaptation to hypoxia, controlling transcriptional programs for glycolysis, angiogenesis, epithelial–mesenchymal transition, immune cell differentiation, and mitochondrial remodeling [PMID:1448077, PMID:8089148, PMID:8756616, PMID:17418790, PMID:21871655]. Under normoxia, prolyl hydroxylase PHD2 hydroxylates Pro402/Pro564 within the oxygen-dependent degradation domain, enabling pVHL-mediated ubiquitination and proteasomal destruction, while FIH-1 hydroxylates Asn803 in the C-terminal transactivation domain to block p300/CBP coactivator recruitment; both hydroxylation events require Fe²⁺ and O₂ as cofactors and are suppressed under hypoxia, permitting HIF-1α stabilization, nuclear translocation, heterodimerization with ARNT (HIF-1β), and transcriptional activation at hypoxia-response elements [PMID:11292861, PMID:11292862, PMID:12912907, PMID:12080085, PMID:7539918]. HIF-1α stability is further tuned by O₂-independent mechanisms including RACK1-mediated Elongin-C/B ubiquitination competing with HSP90 chaperoning, PADI4 citrullination at R698 that blocks VHL binding, and deubiquitination by BAP1 and USP51 [PMID:17361105, PMID:39227578, PMID:36656861, PMID:37816999]. Beyond canonical hypoxia targets, HIF-1α cooperates with lineage-specific factors such as OLIG2 in oligodendrocyte progenitors and RORγt in T cells to activate context-dependent gene programs, and its transcription is itself regulated by KDM4A-mediated H3K9me3 demethylation at the HIF1A locus and STAT1-mediated repression [PMID:33091368, PMID:21871655, PMID:28894274, PMID:36300763]."},"prefetch_data":{"uniprot":{"accession":"Q16665","full_name":"Hypoxia-inducible factor 1-alpha","aliases":["ARNT-interacting protein","Basic-helix-loop-helix-PAS protein MOP1","Class E basic helix-loop-helix protein 78","bHLHe78","Member of PAS protein 1","PAS domain-containing protein 8"],"length_aa":826,"mass_kda":92.7,"function":"Functions as a master transcriptional regulator of the adaptive response to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:18658046, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease (PubMed:22009797). Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 (PubMed:16543236, PubMed:9887100). Activity is enhanced by interaction with NCOA1 and/or NCOA2 (PubMed:10594042). Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP (PubMed:10202154, PubMed:10594042). Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia (PubMed:19528298) (Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent pro-inflammatory state (PubMed:32697943). In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons (PubMed:32697943). Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response (PubMed:32697943)","subcellular_location":"Cytoplasm; Nucleus; Nucleus speckle","url":"https://www.uniprot.org/uniprotkb/Q16665/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HIF1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HIF1A","total_profiled":1310},"omim":[{"mim_id":"621537","title":"CPS1 INTRONIC TRANSCRIPT 1, NONCODING; CPS1IT1","url":"https://www.omim.org/entry/621537"},{"mim_id":"621518","title":"SYNAPTOTAGMIN 17; SYT17","url":"https://www.omim.org/entry/621518"},{"mim_id":"621517","title":"HYPOXIA-INDUCIBLE NONCODING ENHANCER RNA 1","url":"https://www.omim.org/entry/621517"},{"mim_id":"621019","title":"PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG B; PRPF40B","url":"https://www.omim.org/entry/621019"},{"mim_id":"621007","title":"ZINC FINGER PROTEIN 800; ZNF800","url":"https://www.omim.org/entry/621007"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Nuclear bodies","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":423.5}],"url":"https://www.proteinatlas.org/search/HIF1A"},"hgnc":{"alias_symbol":["MOP1","HIF-1alpha","PASD8","HIF1","bHLHe78"],"prev_symbol":[]},"alphafold":{"accession":"Q16665","domains":[{"cath_id":"3.30.450.20","chopping":"79-150_163-204_215-225","consensus_level":"high","plddt":90.1602,"start":79,"end":225},{"cath_id":"3.30.450.20","chopping":"240-360","consensus_level":"high","plddt":93.804,"start":240,"end":360}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16665","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16665-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16665-F1-predicted_aligned_error_v6.png","plddt_mean":60.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HIF1A","jax_strain_url":"https://www.jax.org/strain/search?query=HIF1A"},"sequence":{"accession":"Q16665","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16665.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16665/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16665"}},"corpus_meta":[{"pmid":"13130303","id":"PMC_13130303","title":"Targeting HIF-1 for cancer therapy.","date":"2003","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/13130303","citation_count":5417,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10749844","id":"PMC_10749844","title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia.","date":"2000","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/10749844","citation_count":1430,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16887934","id":"PMC_16887934","title":"Hypoxia-inducible factor-1 (HIF-1).","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16887934","citation_count":1311,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18297062","id":"PMC_18297062","title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis.","date":"2008","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18297062","citation_count":1129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19942427","id":"PMC_19942427","title":"HIF-1: upstream and downstream of cancer metabolism.","date":"2009","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/19942427","citation_count":1072,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23999440","id":"PMC_23999440","title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23999440","citation_count":1050,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11248550","id":"PMC_11248550","title":"HIF-1 and mechanisms of hypoxia sensing.","date":"2001","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11248550","citation_count":1010,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11927290","id":"PMC_11927290","title":"HIF-1 and tumor progression: pathophysiology and therapeutics.","date":"2002","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11927290","citation_count":826,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17925579","id":"PMC_17925579","title":"Hypoxia-inducible factor 1 (HIF-1) pathway.","date":"2007","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/17925579","citation_count":728,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25784597","id":"PMC_25784597","title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25784597","citation_count":452,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19805192","id":"PMC_19805192","title":"Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19805192","citation_count":388,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15780936","id":"PMC_15780936","title":"HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15780936","citation_count":288,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10544245","id":"PMC_10544245","title":"Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10544245","citation_count":282,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30411685","id":"PMC_30411685","title":"Role of HIF-1 in Cancer Progression: Novel Insights. A Review.","date":"2018","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30411685","citation_count":249,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15144945","id":"PMC_15144945","title":"Intratumoral hypoxia, radiation resistance, and HIF-1.","date":"2004","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/15144945","citation_count":197,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14726713","id":"PMC_14726713","title":"HIF-1: an oxygen and metal responsive transcription factor.","date":"2004","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14726713","citation_count":189,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19929412","id":"PMC_19929412","title":"Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.","date":"2009","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/19929412","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34762860","id":"PMC_34762860","title":"Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction.","date":"2021","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/34762860","citation_count":172,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11707426","id":"PMC_11707426","title":"Jab1 interacts directly with HIF-1alpha and regulates its stability.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11707426","citation_count":160,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18815367","id":"PMC_18815367","title":"Distinct size distribution of endogeneous siRNAs in maize: Evidence from deep sequencing in the mop1-1 mutant.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18815367","citation_count":149,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20392254","id":"PMC_20392254","title":"Role of HIF-1alpha in skeletal development.","date":"2010","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20392254","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17361105","id":"PMC_17361105","title":"RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17361105","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15313402","id":"PMC_15313402","title":"New anticancer strategies targeting HIF-1.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15313402","citation_count":128,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32252351","id":"PMC_32252351","title":"Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32252351","citation_count":127,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15313390","id":"PMC_15313390","title":"HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15313390","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"13678535","id":"PMC_13678535","title":"HIF-1 in cell cycle regulation, apoptosis, and tumor progression.","date":"2003","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/13678535","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28318896","id":"PMC_28318896","title":"Role of AHR and HIF-1α in Glioblastoma Metabolism.","date":"2017","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/28318896","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17878221","id":"PMC_17878221","title":"HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes.","date":"2007","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17878221","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36028854","id":"PMC_36028854","title":"ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36028854","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16144691","id":"PMC_16144691","title":"Hypoxia and HIF-1 alpha in chondrogenesis.","date":"2005","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16144691","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27320910","id":"PMC_27320910","title":"The TIP60 Complex Is a Conserved Coactivator of HIF1A.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27320910","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27456341","id":"PMC_27456341","title":"Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27456341","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8557036","id":"PMC_8557036","title":"Schizosaccharomyces pombe Mop1-Mcs2 is related to mammalian CAK.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8557036","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27903434","id":"PMC_27903434","title":"Hypoxia and HIF-1 activation in bacterial infections.","date":"2016","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/27903434","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33401572","id":"PMC_33401572","title":"Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33401572","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24676782","id":"PMC_24676782","title":"Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24676782","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30808328","id":"PMC_30808328","title":"HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia.","date":"2019","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30808328","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34569703","id":"PMC_34569703","title":"m6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34569703","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29652636","id":"PMC_29652636","title":"HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction.","date":"2018","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/29652636","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28701304","id":"PMC_28701304","title":"HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28701304","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30538116","id":"PMC_30538116","title":"Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/30538116","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26346319","id":"PMC_26346319","title":"Modeling the interplay between the HIF-1 and p53 pathways in hypoxia.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26346319","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20033376","id":"PMC_20033376","title":"HIF-1alpha and cancer therapy.","date":"2010","source":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20033376","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31538203","id":"PMC_31538203","title":"HIF-transcribed p53 chaperones HIF-1α.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31538203","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18800226","id":"PMC_18800226","title":"Feminized tassels of maize mop1 and ts1 mutants exhibit altered levels of miR156 and specific SBP-box genes.","date":"2008","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/18800226","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35023280","id":"PMC_35023280","title":"Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35023280","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36351894","id":"PMC_36351894","title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36351894","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22556263","id":"PMC_22556263","title":"Loss of fibroblast HIF-1α accelerates tumorigenesis.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22556263","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29338076","id":"PMC_29338076","title":"Hypoxia-inducible transcription factors, HIF1A and HIF2A, increase in aging mucosal tissues.","date":"2018","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29338076","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30216500","id":"PMC_30216500","title":"The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30216500","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27567526","id":"PMC_27567526","title":"Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27567526","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20958262","id":"PMC_20958262","title":"HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention.","date":"2011","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20958262","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30982460","id":"PMC_30982460","title":"HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30982460","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18713836","id":"PMC_18713836","title":"HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18713836","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12485909","id":"PMC_12485909","title":"ERK and calcium in activation of HIF-1.","date":"2002","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12485909","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35848884","id":"PMC_35848884","title":"HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35848884","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32127571","id":"PMC_32127571","title":"HIF1 driven transcriptional activity regulates steroidogenesis and proliferation of bovine granulosa cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32127571","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18269201","id":"PMC_18269201","title":"The role of HIF-1 in hypoxic response in the skeletal muscle.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/18269201","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16831906","id":"PMC_16831906","title":"Hypoxia and HIF-1alpha in chondrogenesis.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16831906","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15326390","id":"PMC_15326390","title":"Raising the bar: how HIF-1 helps determine tumor radiosensitivity.","date":"2004","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/15326390","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28894274","id":"PMC_28894274","title":"KDM4A regulates HIF-1 levels through H3K9me3.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28894274","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34878158","id":"PMC_34878158","title":"HIF‑1α in cerebral ischemia (Review).","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34878158","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33091368","id":"PMC_33091368","title":"Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function.","date":"2020","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/33091368","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31282018","id":"PMC_31282018","title":"Modeling the regulation of p53 activation by HIF-1 upon hypoxia.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/31282018","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28642579","id":"PMC_28642579","title":"Regulation of glycolysis in brown adipocytes by HIF-1α.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28642579","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24767210","id":"PMC_24767210","title":"Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A.","date":"2014","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/24767210","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35386720","id":"PMC_35386720","title":"Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35386720","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37816999","id":"PMC_37816999","title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37816999","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31966690","id":"PMC_31966690","title":"Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis.","date":"2017","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31966690","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29706348","id":"PMC_29706348","title":"Missense Variants in HIF1A and LACC1 Contribute to Leprosy Risk in Han Chinese.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29706348","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35948068","id":"PMC_35948068","title":"HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System.","date":"2022","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35948068","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28165644","id":"PMC_28165644","title":"HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.","date":"2017","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28165644","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27743086","id":"PMC_27743086","title":"BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.","date":"2016","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/27743086","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31671642","id":"PMC_31671642","title":"Improved Motor Nerve Regeneration by SIRT1/Hif1a-Mediated Autophagy.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31671642","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17982282","id":"PMC_17982282","title":"MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17982282","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30332653","id":"PMC_30332653","title":"The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1α.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30332653","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30651591","id":"PMC_30651591","title":"Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.","date":"2019","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30651591","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32450824","id":"PMC_32450824","title":"Independence of HIF1a and androgen signaling pathways in prostate cancer.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32450824","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24507644","id":"PMC_24507644","title":"Neuroprotective effect of pAkt and HIF-1 α on ischemia rats.","date":"2014","source":"Asian Pacific journal of tropical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24507644","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27090014","id":"PMC_27090014","title":"Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27090014","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31043706","id":"PMC_31043706","title":"Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31043706","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22581642","id":"PMC_22581642","title":"HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions.","date":"2012","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22581642","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36978001","id":"PMC_36978001","title":"NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.","date":"2023","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36978001","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35380485","id":"PMC_35380485","title":"HIF-1α protects osteoblasts from ROS-induced apoptosis.","date":"2022","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/35380485","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29753320","id":"PMC_29753320","title":"Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart.","date":"2018","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/29753320","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35784791","id":"PMC_35784791","title":"Pharmacological inhibition of sphingolipid synthesis reduces ferroptosis by stimulating the HIF-1 pathway.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35784791","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36300763","id":"PMC_36300763","title":"Ablation of endothelial Atg7 inhibits ischemia-induced angiogenesis by upregulating Stat1 that suppresses Hif1a expression.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36300763","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29758199","id":"PMC_29758199","title":"PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29758199","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34870762","id":"PMC_34870762","title":"Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation.","date":"2021","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/34870762","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28366537","id":"PMC_28366537","title":"HIF has Biff - Crosstalk between HIF1a and the family of bHLH/PAS proteins.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28366537","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19766100","id":"PMC_19766100","title":"TNFalpha induces HIF-1alpha expression through activation of IKKbeta.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19766100","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39227578","id":"PMC_39227578","title":"Citrullination modulation stabilizes HIF-1α to promote tumour progression.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39227578","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16888453","id":"PMC_16888453","title":"Leukocyte's Hif-1 expression and training-induced erythropoietic response in swimmers.","date":"2006","source":"Medicine and science in sports and exercise","url":"https://pubmed.ncbi.nlm.nih.gov/16888453","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36656861","id":"PMC_36656861","title":"BAP1 is a novel regulator of HIF-1α.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36656861","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37733588","id":"PMC_37733588","title":"FSHR-mTOR-HIF1 signaling alleviates mouse follicles from AMPK-induced atresia.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37733588","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36174675","id":"PMC_36174675","title":"Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36174675","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36691538","id":"PMC_36691538","title":"Hypoxia-Induced Autophagy Is Involved in Radioresistance via HIF1A-Associated Beclin-1 in Glioblastoma Multiforme.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/36691538","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35937565","id":"PMC_35937565","title":"Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A.","date":"2022","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35937565","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29447016","id":"PMC_29447016","title":"TGF-b1 or hypoxia enhance glucose metabolism and lactate production via HIF1A signaling in tendon cells.","date":"2018","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/29447016","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38786726","id":"PMC_38786726","title":"Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells.","date":"2024","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/38786726","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7539918","id":"PMC_7539918","title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7539918","citation_count":5108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11292861","id":"PMC_11292861","title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11292861","citation_count":4644,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10353251","id":"PMC_10353251","title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10353251","citation_count":4200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11292862","id":"PMC_11292862","title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11292862","citation_count":3938,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8756616","id":"PMC_8756616","title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8756616","citation_count":3206,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11598268","id":"PMC_11598268","title":"A conserved family of prolyl-4-hydroxylases that modify HIF.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11598268","citation_count":2101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1448077","id":"PMC_1448077","title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1448077","citation_count":2065,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20965423","id":"PMC_20965423","title":"Hypoxia-inducible factors and the response to hypoxic stress.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20965423","citation_count":1898,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9653127","id":"PMC_9653127","title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9653127","citation_count":1777,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15652751","id":"PMC_15652751","title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.","date":"2005","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/15652751","citation_count":1721,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7836384","id":"PMC_7836384","title":"Purification and characterization of hypoxia-inducible factor 1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7836384","citation_count":1677,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8089148","id":"PMC_8089148","title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8089148","citation_count":1419,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21871655","id":"PMC_21871655","title":"Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21871655","citation_count":1335,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10878807","id":"PMC_10878807","title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10878807","citation_count":1295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25865369","id":"PMC_25865369","title":"Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.","date":"2015","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/25865369","citation_count":1288,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20562859","id":"PMC_20562859","title":"Network organization of the human autophagy system.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20562859","citation_count":1286,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12080085","id":"PMC_12080085","title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12080085","citation_count":1253,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11823643","id":"PMC_11823643","title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11823643","citation_count":1247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21620138","id":"PMC_21620138","title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21620138","citation_count":1209,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8387214","id":"PMC_8387214","title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8387214","citation_count":1207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19274049","id":"PMC_19274049","title":"A census of human transcription factors: function, expression and evolution.","date":"2009","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19274049","citation_count":1191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11641274","id":"PMC_11641274","title":"FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11641274","citation_count":1173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14645546","id":"PMC_14645546","title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14645546","citation_count":1167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12912907","id":"PMC_12912907","title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12912907","citation_count":1137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12242281","id":"PMC_12242281","title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12242281","citation_count":1012,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17418790","id":"PMC_17418790","title":"HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17418790","citation_count":996,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45623,"output_tokens":6775,"usd":0.119247},"stage2":{"model":"claude-opus-4-6","input_tokens":10693,"output_tokens":4947,"usd":0.26571},"total_usd":0.842257,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":57602,"output_tokens":10723,"usd":0.166825},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":15505,"output_tokens":4645,"usd":0.290475}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"HIF-1 is a heterodimeric transcription factor consisting of a constitutively expressed HIF-1β subunit and an oxygen-regulated HIF-1α subunit that activates transcription of genes involved in angiogenesis, glucose metabolism, cell survival, and invasion by binding hypoxia-response elements (HREs).\",\n      \"method\": \"Transcriptional reporter assays, gene expression studies, loss-of-function experiments\",\n      \"journal\": \"Nature reviews. Cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — foundational mechanistic framework replicated across many labs\",\n      \"pmids\": [\"13130303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HIF-1α is subjected to O2-dependent hydroxylation of proline residues 402 and/or 564 by PHD2 (using O2 and α-ketoglutarate as substrates), which promotes VHL binding, ubiquitination, and proteasomal degradation; additionally, asparagine 803 is hydroxylated by FIH-1, blocking p300/CBP coactivator binding.\",\n      \"method\": \"Hydroxylation assays, mutagenesis of proline/asparagine residues, co-immunoprecipitation with VHL, reporter assays\",\n      \"journal\": \"Science's STKE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution and mutagenesis, replicated across multiple labs\",\n      \"pmids\": [\"17925579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In normoxia, hydroxylation of two proline residues and acetylation of a lysine residue at the oxygen-dependent degradation domain (ODDD) of HIF-1α triggers its association with pVHL E3 ligase complex, leading to ubiquitin-proteasomal degradation; in hypoxia, HIF-1α becomes stable and interacts with coactivators p300/CBP to regulate target genes.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, reporter assays, mutagenesis\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — well-established mechanistic pathway replicated in multiple studies\",\n      \"pmids\": [\"16887934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1α; RACK1 promotes O2/PHD/VHL-independent proteasomal degradation of HIF-1α by recruiting Elongin-C/B ubiquitin ligase complex, while HSP90 binding stabilizes HIF-1α.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping (PAS-A), ubiquitination assays, proteasome inhibition experiments\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, domain mapping, and functional degradation assays; replicated mechanistic findings\",\n      \"pmids\": [\"17361105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HIF-1α interacts with Hsp90 via its bHLH-PAS domain under normoxia but not hypoxia; Hsp90 is not co-translocated to the nucleus with HIF-1α, and Hsp90 activity is required for HIF-1 activation in hypoxia (geldanamycin inhibits this).\",\n      \"method\": \"Co-immunoprecipitation of EGFP-HIF-1α fusion protein with Hsp90, domain mapping, pharmacological inhibition with geldanamycin\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with domain mapping and pharmacological validation, single lab\",\n      \"pmids\": [\"10544245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Jab1 (Jun activation domain-binding protein-1/COP9 signalosome subunit 5) directly interacts with HIF-1α, enhances HIF-1 transcriptional activity under hypoxia, increases HIF-1α protein stability, and interferes with p53 binding to HIF-1α.\",\n      \"method\": \"Yeast two-hybrid screening, GST pull-down, co-immunoprecipitation in HEK293 cells, VEGF reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by GST pulldown and co-IP with functional reporter validation, single lab\",\n      \"pmids\": [\"11707426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HIF-1 directly regulates transcription of the TWIST gene by binding to a hypoxia-response element (HRE) in the TWIST proximal promoter, thereby promoting epithelial-mesenchymal transition (EMT) and metastasis.\",\n      \"method\": \"ChIP assay, luciferase reporter assay with HRE-containing TWIST promoter, siRNA knockdown of TWIST in HIF-1α-overexpressing cells, in vivo metastasis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP, reporter assays, and functional rescue experiments with multiple orthogonal methods\",\n      \"pmids\": [\"18297062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HIF-1α displaces the transcriptional activator Myc from Sp1 binding sites to repress MutSα (MSH2-MSH6) expression in a p53-dependent manner; Sp1 serves as a molecular switch recruiting HIF-1α to MSH2/MSH6 gene promoters under hypoxia, causing genetic instability.\",\n      \"method\": \"ChIP assay, promoter reporter assays, co-immunoprecipitation, siRNA knockdown, microsatellite instability analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP and reporter assays with mechanistic mutagenesis and clinical correlation, single high-quality study\",\n      \"pmids\": [\"15780936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HIF-1 transcriptionally activates genes encoding glucose transporters, glycolytic enzymes, pyruvate dehydrogenase kinase 1 (which shunts pyruvate away from mitochondria), and BNIP3 (which triggers selective mitochondrial autophagy), thereby reprogramming cancer cell metabolism toward glycolysis.\",\n      \"method\": \"ChIP, reporter assays, gene expression analysis, metabolic measurements in HIF-1α loss-of-function cells\",\n      \"journal\": \"Current opinion in genetics & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — established by multiple orthogonal approaches replicated across labs\",\n      \"pmids\": [\"19942427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Acriflavine binds directly to HIF-1α and HIF-2α and inhibits HIF-1 dimerization and transcriptional activity, reducing tumor growth and vascularization in prostate cancer xenografts.\",\n      \"method\": \"Cell-based screening assay, direct binding assay, tumor xenograft mouse models, intratumoral gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding demonstrated with functional in vitro and in vivo validation\",\n      \"pmids\": [\"19805192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The TIP60 (KAT5) complex acts as a conserved coactivator of HIF1A; HIF1A interacts with and recruits TIP60 to chromatin, and TIP60 is required for HIF1A-dependent chromatin modification and RNA polymerase II activation in hypoxia but not for HIF1A's association with target gene loci.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, RNA-seq, genetic knockdown in Drosophila and human colorectal cancer cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, ChIP, and loss-of-function studies in two species with multiple orthogonal methods\",\n      \"pmids\": [\"27320910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MgcRacGAP interacts specifically with HIF-1α (confirmed in vitro and in vivo) and overexpression of MgcRacGAP inhibits HIF-1α transcriptional activity without altering HIF-1α protein levels or subcellular localization; inhibition requires the MgcRacGAP domain that contacts HIF-1α.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation in mammalian cells, HIF-1 reporter assay, domain deletion analysis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple binding assays plus functional reporter, single lab\",\n      \"pmids\": [\"17982282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HIF-1 is strongly induced in keratinocytes by mechanical wounding through PI3K pathway activation independent of oxygen availability; HIF-1α is required for wound-induced keratinocyte migration by directly regulating laminin-332 expression, specifically activating the laminin α3 chain promoter.\",\n      \"method\": \"In vitro scratch wound assay, PI3K inhibition, HIF-1α knockdown/inhibition, luciferase reporter assay for laminin α3 promoter, wound closure quantification\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic inhibition with promoter reporter assay and functional migration readout\",\n      \"pmids\": [\"18713836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF-1α transcriptionally upregulates p53 expression by binding to five HREs in the p53 promoter; in hypoxia, this HIF-1α-induced p53 protein (transcriptionally inactive) binds and chaperones HIF-1α to stabilize its binding at downstream DNA response elements, forming a positive feedback loop that increases HIF-regulated gene synthesis.\",\n      \"method\": \"ChIP, promoter reporter assays, co-immunoprecipitation, siRNA knockdown, gene expression analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and co-IP with reporter assays, single lab\",\n      \"pmids\": [\"31538203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KDM4A histone demethylase controls HIF-1α levels by removing the repressive H3K9me3 mark at the HIF1A locus; loss or inactivation of KDM4A accumulates H3K9me3 at the HIF1A gene, decreasing HIF1A mRNA and protein, and reducing HIF-1α-mediated transcriptional responses.\",\n      \"method\": \"KDM4A knockdown/inhibition, H3K9me3 ChIP at HIF1A locus, qRT-PCR, Western blot, invasion/migration assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP linking chromatin mark to HIF1A transcription with functional KO phenotype, single lab\",\n      \"pmids\": [\"28894274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Intermittent hypoxia increases HIF-1α protein through KDM4A/B/C histone demethylase-mediated removal of H3K9 trimethylation near the HIF1A locus, increasing HIF1A mRNA; this contrasts with chronic hypoxia which decreases KDM4A/B/C activity and causes H3K9 hypertrimethylation at the HIF1A locus.\",\n      \"method\": \"ChIP for H3K9me3 at HIF1A locus, KDM4 activity assays, qRT-PCR, Western blot under intermittent vs chronic hypoxia conditions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional gene expression readout comparing two hypoxia regimes, single lab\",\n      \"pmids\": [\"36174675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PADI4 directly interacts with and citrullinates HIF-1α at arginine R698; this citrullination blocks VHL binding to HIF-1α, thereby antagonizing HIF-1α ubiquitination and proteasomal degradation and stabilizing HIF-1α to promote tumor progression.\",\n      \"method\": \"Co-immunoprecipitation, citrullination assay, mutagenesis of R698, ubiquitination assay, VHL binding assay, computational modeling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution of citrullination, mutagenesis of modification site, and mechanistic VHL binding competition assay\",\n      \"pmids\": [\"39227578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP51 directly binds Elongin C (ELOC) and forms a complex with VHL E3 ligase to deubiquitinate HIF1A, stabilizing it; SENP1-mediated deSUMOylation of ELOC at K32 promotes USP51-ELOC binding and thereby HIF1A stabilization. HIF1A in turn transcriptionally upregulates USP51, forming a positive feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, deubiquitination assay, luciferase reporter for USP51 promoter, SUMO mutagenesis, ChIP\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct deubiquitination assay, co-IP of complex components, mutagenesis, and ChIP with multiple orthogonal validations\",\n      \"pmids\": [\"37816999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BAP1 binds and deubiquitylates HIF-1α during hypoxia, stabilizing it; the interaction is mediated by the BAP1 C-terminal domain (residues I675, F678, I679, L691) binding the N-terminal region of HIF-1α; loss of BAP1 reduces HIF-1α protein levels in hypoxia.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitylation assay, alanine mutagenesis of BAP1 residues, computational modeling, IHC of tumor biopsies, siRNA knockdown\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct deubiquitylation demonstrated with mutagenesis defining interaction domain and functional consequence\",\n      \"pmids\": [\"36656861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNFα enhances HIF-1α protein expression (not mRNA) through IKKβ; IKKβ is required for TNFα-mediated HIF-1α accumulation under normoxic and hypoxia-mimicking conditions, and IKKβ knockout MEFs show decreased VEGF expression.\",\n      \"method\": \"IKKβ stable overexpression and knockdown, pharmacological IKKβ inhibition, Western blot for HIF-1α protein vs mRNA, VEGF expression in IKKβ-KO MEFs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological IKKβ manipulation with protein vs mRNA distinction, single lab\",\n      \"pmids\": [\"19766100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HIF1 directly binds the PKM gene locus (demonstrated by ChIP) and mediates a switch from the PKM1 to PKM2 isoform of pyruvate kinase following myocardial infarction, with concomitant upregulation of splicing factors hnRNPA1, hnRNPA2B1, and Ptbp1.\",\n      \"method\": \"ChIP for HIF1 at PKM locus, RNA-seq after LAD ligation in mice, splicing factor expression analysis\",\n      \"journal\": \"Physiological genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct HIF1 binding at PKM combined with in vivo transcriptomic data, single lab\",\n      \"pmids\": [\"29652636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HIF1A binds to HRE elements in the WASF3 (WAVE3) promoter and directly activates WASF3 transcription under hypoxia; WASF3 knockdown abolishes hypoxia-induced invasion and motility, placing WASF3 downstream of HIF1A in metastatic signaling.\",\n      \"method\": \"ChIP assay for HIF1A at WASF3 HRE elements, luciferase reporter with WASF3 minimal promoter, WASF3 siRNA knockdown, scratch wound/invasion assays\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and reporter plus functional epistasis by knockdown, single lab\",\n      \"pmids\": [\"22581642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HIF1a activates non-canonical transcriptional targets in oligodendrocyte progenitor cells (OPCs) through interaction with the OPC-specific transcription factor OLIG2; HIF1a-OLIG2 driven targets (including Ascl2 and Dlx3) are sufficient to block oligodendrocyte differentiation by suppressing Sox10.\",\n      \"method\": \"ChIP-seq, RNA-seq, genetic HIF1a accumulation model in PSC-derived OPCs, OLIG2 co-immunoprecipitation, chemical screening with MEK/ERK inhibitors\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq plus co-IP with functional differentiation rescue experiments using multiple orthogonal approaches\",\n      \"pmids\": [\"33091368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FTO (m6A demethylase) deficiency increases m6A methylation on Hif1a mRNA, which is recognized by the m6A reader YTHDC2, facilitating Hif1a mRNA translation and increasing HIF1A protein abundance; elevated HIF1A then activates transcription of thermogenic genes (Ppargc1a, Prdm16, Pparg) to promote UCP1 expression and white-to-beige adipocyte transition.\",\n      \"method\": \"m6A-seq, RIP for YTHDC2 binding to Hif1a mRNA, adipose-specific FTO knockout mice, polysome profiling/translation assay, HIF1A ChIP for thermogenic gene promoters\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — m6A mapping, reader protein RIP, translation assays, and ChIP with genetic KO model\",\n      \"pmids\": [\"34569703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CF-specific deletion of Hif-1a results in increased mitochondrial ROS in cardiac fibroblasts following myocardial infarction, leading to excessive CF proliferation and scarring; HIF-1α in CFs normally suppresses CF proliferation by limiting mitochondrial ROS, a phenotype rescued by MitoTEMPO antioxidant treatment.\",\n      \"method\": \"CF-specific Hif-1a conditional knockout mice, single-cell RNA-seq, 3D engineered cardiac microtissues, MitoParaquat/MitoTEMPO pharmacological rescue, ROS measurement\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific KO with defined phenotype, scRNA-seq, pharmacological rescue confirming ROS mechanism\",\n      \"pmids\": [\"34762860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense: HIF1A mediates increased autophagy while NFAT5 directs targeting of intracellular E. coli to acidic autolysosomal compartments; this HIF1A-dependent autophagy is required for enhanced bacterial killing in high-salt macrophage conditions.\",\n      \"method\": \"HIF1A conditional KO macrophages, autophagy flux assays, bacterial colony-forming unit assays, pharmacological HIF1A stabilization (DMOG), ROS inhibition, lysosomal pH measurement\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined bacterial killing phenotype and pharmacological validation, single lab\",\n      \"pmids\": [\"30982460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Calcium/calmodulin and the ERK pathway are required for hypoxia-induced HIF-1 transcriptional activity: ionomycin activates HIF-1 transcriptionally without affecting HIF-1α protein level or DNA binding; calmodulin dominant-negative mutant, BAPTA calcium chelation, and PD98059 (ERK inhibitor) all block hypoxia-induced HIF-1 activation, placing calcium upstream of ERK in the hypoxic signaling pathway.\",\n      \"method\": \"HIF-1 reporter assays, dominant-negative calmodulin, BAPTA intracellular calcium chelation, PD98059 ERK pathway inhibition, KN-93 CaM kinase inhibition\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic dissection of signaling pathway with reporter assay readout, single lab\",\n      \"pmids\": [\"12485909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ATG7 ablation in endothelial cells upregulates STAT1 in an autophagy-independent manner; STAT1 binds the HIF1A promoter and suppresses HIF1A transcription, impairing ischemia-induced angiogenesis; mechanistically, ATG7 in the cytoplasm associates with ZNF148 to prevent its nuclear translocation and STAT1 upregulation.\",\n      \"method\": \"EC-specific Atg7 KO mice, ChIP for STAT1 at HIF1A promoter, HIF1A overexpression rescue, ZNF148 co-immunoprecipitation with ATG7/KPNB1, fludarabine STAT1 inhibition in vivo\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with ChIP demonstrating STAT1 binding to HIF1A promoter, co-IP mechanistic studies, and pharmacological rescue\",\n      \"pmids\": [\"36300763\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HIF-1α is an oxygen-sensitive bHLH-PAS transcription factor that is constitutively synthesized but rapidly degraded under normoxia via PHD2-mediated hydroxylation of Pro402/564 (promoting VHL E3 ubiquitin ligase binding and proteasomal degradation) and FIH-1-mediated hydroxylation of Asn803 (blocking p300/CBP coactivator binding); under hypoxia these hydroxylases are inhibited, allowing HIF-1α to accumulate, dimerize with HIF-1β, recruit coactivators including p300/CBP and the TIP60 complex, and bind HREs to transcriptionally activate hundreds of genes controlling glycolysis, angiogenesis, metastasis, and cell survival; its stability is further regulated by O2-independent pathways including RACK1-mediated (HSP90-competing) ubiquitination, deubiquitination by BAP1 and USP51, citrullination at R698 by PADI4 (blocking VHL binding), and chromatin-level control of HIF1A transcription via KDM4A-dependent H3K9me3 demethylation, as well as translational control by m6A modification.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"A nuclear factor (HIF-1) is induced by hypoxia via de novo protein synthesis and binds to a site in the human erythropoietin gene enhancer required for transcriptional activation, establishing HIF-1 as a hypoxia-responsive transcriptional activator.\",\n      \"method\": \"DNase I footprinting, EMSA, reporter gene transfection, cycloheximide inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical binding assay with mutagenesis, foundational paper with >2000 citations\",\n      \"pmids\": [\"1448077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"HIF-1 DNA-binding activity is induced by hypoxia in a wide variety of mammalian cell types (not only EPO-producing cells), establishing HIF-1 as a general mediator of transcriptional responses to hypoxia.\",\n      \"method\": \"EMSA, reporter gene transfection, mutagenesis across multiple cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple cell lines, reporter assays with mutagenesis, >1200 citations\",\n      \"pmids\": [\"8387214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HIF-1 directly binds to HRE sequences in the promoters of glycolytic enzyme genes (aldolase A, PGK1, enolase 1, LDHA, PFKL) and activates their transcription under hypoxia, linking HIF-1 to metabolic reprogramming.\",\n      \"method\": \"EMSA with affinity-purified HIF-1, reporter gene transfection with HRE sequences, RNA induction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA binding demonstrated with purified protein plus functional reporter assays, >1400 citations\",\n      \"pmids\": [\"8089148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HIF-1 is a heterodimer of two bHLH-PAS proteins: HIF-1α (most closely related to Drosophila Sim) and HIF-1β (ARNT). Both subunits are induced at 1% O₂ and decay upon reoxygenation.\",\n      \"method\": \"Protein purification, biochemical characterization, molecular cloning, RNA/protein level measurements under hypoxia\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — protein purification + cloning + functional characterization, >5000 citations\",\n      \"pmids\": [\"7539918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HIF-1 purified as a heterodimer (~120 kDa HIF-1α and 91–94 kDa HIF-1β subunits); both subunits contact DNA directly; HIF-1 binds specifically to the wild-type EPO enhancer HIF-1 binding site.\",\n      \"method\": \"Affinity chromatography purification, UV cross-linking, glycerol gradient sedimentation, EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification with multiple orthogonal methods, >1600 citations\",\n      \"pmids\": [\"7836384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"HIF-1 directly activates VEGF transcription by binding to a hypoxia-response element (HRE) in the VEGF 5'-flanking region; dominant-negative HIF-1α abolishes hypoxic VEGF induction; HIF-1β (ARNT)-null cells fail to induce VEGF mRNA.\",\n      \"method\": \"Reporter gene assays, HRE mutagenesis, dominant-negative cotransfection, ARNT-null cell lines\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of HRE + dominant-negative + null cells, >3200 citations\",\n      \"pmids\": [\"8756616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HIF-1α contains an oxygen-dependent degradation (ODD) domain (~200 aa in the central region) that controls its ubiquitin-proteasome degradation; deletion of the entire ODD yields a stable, functional HIF-1α under normoxia; ODD alone confers O₂-dependent instability when fused to a stable protein.\",\n      \"method\": \"Domain deletion mutagenesis, fusion-protein stability assays, heterodimerization and transactivation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with multiple functional readouts, >1700 citations\",\n      \"pmids\": [\"9653127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"pVHL targets HIF-α subunits for oxygen-dependent proteolysis: VHL-defective cells constitutively stabilize HIF-α; re-expression of pVHL restores O₂-dependent instability; pVHL and HIF-α co-immunoprecipitate and the interaction is iron-dependent.\",\n      \"method\": \"VHL re-expression in VHL-null cells, co-immunoprecipitation, iron chelation experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus genetic rescue in VHL-null cells, >4200 citations\",\n      \"pmids\": [\"10353251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Hsp90 interacts with the bHLH-PAS domain of HIF-1α under normoxia but not hypoxia; Hsp90 is not co-translocated to the nucleus with HIF-1α; Hsp90 activity is required for HIF-1 activation (inhibited by geldanamycin).\",\n      \"method\": \"EGFP-HIF-1α co-immunoprecipitation in COS-7 cells, domain mapping, geldanamycin pharmacological inhibition\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with domain mapping and pharmacological validation, single lab\",\n      \"pmids\": [\"10544245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"pVHL, through its β-domain, directly binds HIF-α and targets it for ubiquitination in an α-domain-dependent manner, providing the first evidence that pVHL functions analogously to an F-box protein recruiting substrates to the ubiquitination machinery.\",\n      \"method\": \"Direct binding assays, ubiquitination assays, domain mutagenesis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding plus ubiquitination reconstitution with domain mutagenesis, >1295 citations\",\n      \"pmids\": [\"10878807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HIF-1α is targeted for VHL-mediated ubiquitylation through O₂-regulated hydroxylation of proline residue P564 by a HIF-α prolyl-hydroxylase (HIF-PH/PHD); the reaction requires dioxygen and Fe²⁺ as cofactors, identifying PHD as the direct cellular oxygen sensor.\",\n      \"method\": \"Peptide binding assays, site-directed mutagenesis (P564), mass spectrometry, in vitro hydroxylation with Fe²⁺/O₂\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + biochemical reconstitution + MS, >4600 citations\",\n      \"pmids\": [\"11292861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"pVHL binds HIF-1α-derived peptide only when a conserved proline is hydroxylated; proline hydroxylation requires molecular O₂ and Fe²⁺, placing this modification as the key oxygen-sensing step in HIF-1α degradation.\",\n      \"method\": \"Peptide binding assay, site-directed mutagenesis, Fe²⁺/O₂ dependency experiments\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with mutagenesis, >3900 citations\",\n      \"pmids\": [\"11292862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FIH-1 binds both HIF-1α and pVHL; FIH-1 inhibits HIF-1α transactivation function; VHL also acts as a transcriptional corepressor by recruiting histone deacetylases to inhibit HIF-1α transactivation independently of protein degradation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, reporter assays, HDAC recruitment assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple interaction methods plus functional reporter assays, >1173 citations\",\n      \"pmids\": [\"11641274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Jab1 (COP9 signalosome subunit 5) directly interacts with HIF-1α, enhances HIF-1 transcriptional activity, increases HIF-1α protein stability, and interferes with p53–HIF-1α binding in a Jab1-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by GST pull-down and co-IP with functional validation, single lab\",\n      \"pmids\": [\"11707426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A conserved family of HIF prolyl-hydroxylase (HPH/PHD) enzymes hydroxylates the ODD proline of HIF-1α; forced HIF-1α expression under normoxia is attenuated by HPH co-expression; RNAi knockdown of HPH in Drosophila cells elevates a hypoxia-inducible gene under normoxia.\",\n      \"method\": \"Sequence homology, co-expression normoxic stabilization assay, Drosophila cell RNAi\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gain-of-function + RNAi loss-of-function in two systems, >2100 citations\",\n      \"pmids\": [\"11598268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FIH-1 is an asparaginyl hydroxylase (Fe[II]-dependent, O₂-dependent dioxygenase) that hydroxylates a conserved asparagine in the C-terminal transactivation domain (CAD) of HIF-1α, blocking p300/CBP coactivator recruitment under normoxia.\",\n      \"method\": \"In vitro hydroxylation assay, mass spectrometry, Asn→Ala mutagenesis, p300 interaction assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — enzymatic reconstitution with MS identification and mutagenesis, >1253 citations\",\n      \"pmids\": [\"12080085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hypoxic induction of the HIF CAD requires abrogation of asparagine hydroxylation, which in normoxia prevents p300 coactivator interaction; Asn→Ala substitution yields constitutive p300 interaction and strong transcriptional activity; full HIF induction requires abrogation of both Pro and Asn hydroxylation.\",\n      \"method\": \"Dioxygenase inhibitors, Asn mutagenesis, p300 interaction assays, transcriptional reporter assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + pharmacological inhibition + coactivator binding reconstitution, >1247 citations\",\n      \"pmids\": [\"11823643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"mTOR signaling promotes HIF-1α stabilization and HIF-1 transactivation; rapamycin inhibits hypoxia- and CoCl₂-induced HIF-1α accumulation; the ODD domain is the critical target of the rapamycin-sensitive mTOR pathway for HIF-1α stabilization.\",\n      \"method\": \"Rapamycin pharmacological inhibition, wild-type/rapamycin-resistant mTOR transfection, GAL4-HIF-1α domain mapping, reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gain/loss-of-function with domain mapping and pharmacological confirmation, >1012 citations\",\n      \"pmids\": [\"12242281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Calcium/calmodulin signaling and ERK pathway activation contribute to HIF-1 transcriptional activity under hypoxia; ionomycin additively activates HIF-1 without affecting HIF-1α protein level; calmodulin dominant-negative or BAPTA (Ca²⁺ chelator) inhibits hypoxia-induced HIF-1 activation; PD98059 (MEK inhibitor) blocks HIF-1 activation, placing Ca²⁺/calmodulin upstream of ERK.\",\n      \"method\": \"Pharmacological inhibitors, dominant-negative calmodulin, intracellular Ca²⁺ chelation, reporter assays\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological tools with dominant-negative approach, single lab\",\n      \"pmids\": [\"12485909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PHD2 is the key oxygen sensor that sets low steady-state HIF-1α levels in normoxia; siRNA silencing of PHD2 alone is sufficient to stabilize and activate HIF-1α in all human cells tested under normoxia; silencing PHD1 or PHD3 has no effect on HIF-1α stability.\",\n      \"method\": \"siRNA knockdown of PHD1, PHD2, PHD3 individually in multiple human cell lines, HIF-1α stability and transcriptional activity assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic RNAi with multiple cell lines and functional readouts, >1137 citations\",\n      \"pmids\": [\"12912907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HIF-1α (not HIF-2α) is specifically required for glycolytic gene expression; HIF-2α can regulate a subset of broadly expressed hypoxia-inducible genes, demonstrating distinct non-redundant transcriptional programs for the two HIF-α paralogs.\",\n      \"method\": \"DNA microarray analysis of HIF-1α−/− cells, tetracycline-regulated stabilized HIF-1α or HIF-2α expression in HEK293 cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide comparison using isogenic cell lines with controlled expression, >1167 citations\",\n      \"pmids\": [\"14645546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Succinate accumulation from SDH inhibition inhibits HIF-α prolyl hydroxylases in the cytosol, leading to HIF-1α stabilization and activation, thus linking mitochondrial TCA cycle dysfunction to HIF-1 oncogenic signaling.\",\n      \"method\": \"SDH inhibition/knockdown, prolyl hydroxylase activity assay with succinate, HIF-1α stability assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay demonstrating PHD inhibition by succinate plus cellular validation, >1721 citations\",\n      \"pmids\": [\"15652751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HIF-1α promotes genetic instability by transcriptionally repressing MSH2 and MSH6 (MutSα mismatch repair complex) through displacing Myc from Sp1 binding sites at their promoters, in a p53-dependent manner.\",\n      \"method\": \"Reporter assays, chromatin immunoprecipitation, siRNA knockdown, co-immunoprecipitation, clinical specimen correlation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, reporter assays, siRNA knockdown, multiple orthogonal methods, replicated in clinical specimens\",\n      \"pmids\": [\"15780936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1α and promotes O₂/PHD/VHL-independent proteasomal degradation of HIF-1α by recruiting Elongin-C/B E3 ubiquitin ligase; RACK1 is required for HSP90 inhibitor-induced HIF-1α degradation.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, ubiquitination assays, RACK1 siRNA knockdown\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific competition assay, ubiquitination reconstitution, RNAi validation, replicated in multiple contexts\",\n      \"pmids\": [\"17361105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MgcRacGAP directly binds HIF-1α (verified in vitro and in vivo); MgcRacGAP overexpression inhibits HIF-1α transcriptional activity without affecting HIF-1α protein levels or subcellular localization; inhibition depends on the MgcRacGAP domain that interacts with HIF-1α.\",\n      \"method\": \"Yeast two-hybrid, in vitro pull-down, co-immunoprecipitation in mammalian cells, reporter assays, domain mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast 2-hybrid confirmed by pull-down and co-IP with functional assay, single lab\",\n      \"pmids\": [\"17982282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HIF-1 regulates COX4 subunit composition in mammalian cells under hypoxia: HIF-1 activates transcription of COX4-2 and LON (a mitochondrial protease that degrades COX4-1), switching COX subunit composition to optimize respiratory efficiency at low O₂.\",\n      \"method\": \"ChIP, reporter assays, siRNA knockdown, oxygen consumption/ROS/ATP measurements, in vivo mouse model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP + reporter + functional metabolic assays + in vivo validation, >996 citations\",\n      \"pmids\": [\"17418790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HIF-1 directly binds the HRE in the TWIST proximal promoter to transcriptionally activate TWIST, thereby promoting epithelial-mesenchymal transition (EMT) and cancer metastasis; siRNA knockdown of TWIST reverses HIF-1α-driven EMT.\",\n      \"method\": \"ChIP, reporter assays, siRNA knockdown, EMT/invasion assays, clinical specimen analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + reporter + siRNA rescue experiments, >1129 citations\",\n      \"pmids\": [\"18297062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HIF1 transcription factor is activated by mechanical wounding of keratinocytes (via PI3K pathway, independently of O₂), and directly regulates laminin-332 (laminα3 chain promoter) expression to promote keratinocyte migration and wound re-epithelialization.\",\n      \"method\": \"HIF-1α protein stabilization assays, PI3K inhibition, siRNA knockdown of HIF-1α, reporter assay of laminin α3 promoter, scratch wound assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter + siRNA knockdown + functional wound assay, single lab\",\n      \"pmids\": [\"18713836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Acriflavine directly binds HIF-1α and HIF-2α and inhibits HIF-1 dimerization and transcriptional activity; this small molecule prevents tumor growth and vascularization in prostate cancer xenografts.\",\n      \"method\": \"Cell-based reporter screening, direct binding assay, dimerization assay, xenograft tumor models\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding + functional dimerization assay + in vivo xenograft, multiple orthogonal methods\",\n      \"pmids\": [\"19805192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNFα enhances HIF-1α protein expression (not mRNA) through IKKβ in breast cancer cells; IKKβ stable overexpression increases HIF-1α protein; IKKβ siRNA depletion or pharmacological inhibition (Bay 11-7082) reduces TNFα-induced HIF-1α; IKKβ-knockout MEFs show reduced VEGF expression.\",\n      \"method\": \"Western blot, siRNA/shRNA knockdown, IKKβ stable overexpression, pharmacological IKKβ inhibitor, IKKβ-null MEFs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic and pharmacological approaches, single lab\",\n      \"pmids\": [\"19766100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKM2 directly interacts with HIF-1α and functions as a transcriptional coactivator, enhancing HIF-1 target gene transactivation by promoting p300 recruitment to HREs; PHD3 hydroxylates PKM2 at P403/P408, enhancing PKM2–HIF-1α interaction and coactivator function; this creates a positive feedback loop driving glucose metabolism reprogramming in cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, mass spectrometry (hydroxylation), anti-hydroxyproline antibody, PHD3 knockdown, metabolic assays (glucose uptake, lactate, O₂ consumption)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-IP + ChIP + MS identification of modification + functional metabolic assays, >1209 citations\",\n      \"pmids\": [\"21620138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HIF-1 directly activates RORγt transcription and forms a tertiary complex with RORγt and p300 at the IL-17 promoter to drive TH17 differentiation; concurrently HIF-1 binds Foxp3 and targets it for proteasomal degradation, attenuating Treg development; this occurs under both normoxic and hypoxic conditions.\",\n      \"method\": \"ChIP, reporter assays, co-immunoprecipitation, proteasome inhibition, HIF-1α conditional knockout mice (T cell-specific), EAE model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP + co-IP + conditional KO in vivo model, multiple orthogonal methods, >1335 citations\",\n      \"pmids\": [\"21871655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HIF1A directly binds HRE elements in the WASF3 (WAVE3) gene promoter (demonstrated by ChIP) and activates its transcription under hypoxia, promoting cancer cell motility and invasion; WASF3 knockdown abrogates the hypoxic migratory response.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown of WASF3, scratch wound migration assay\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + reporter + functional migration assay, single lab\",\n      \"pmids\": [\"22581642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Microbiota-derived butyrate drives O₂ consumption by intestinal epithelial cells, stabilizing HIF-1 and enhancing barrier function; antibiotic depletion of microbiota reduces colonic butyrate and HIF expression; butyrate effects on barrier function are lost in HIF-null cells, linking butyrate metabolism to HIF-1 stabilization.\",\n      \"method\": \"Antibiotic microbiota depletion, butyrate supplementation, germ-free mice, HIF-null cells, O₂ sensing dye assays\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models (KO, germ-free, antibiotic) with mechanistic validation, >1288 citations\",\n      \"pmids\": [\"25865369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TIP60 (KAT5) histone acetyltransferase complex is a conserved coactivator of HIF1: HIF1A interacts with and recruits TIP60 to chromatin; TIP60 is required for HIF1A-dependent chromatin modification and RNA Pol II activation at HREs but not for HIF1A binding to target genes.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, genetic knockdown in Drosophila and human colorectal cancer cells, RNA Pol II ChIP\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP + ChIP-seq + genetic loss-of-function in two organisms, multiple orthogonal methods\",\n      \"pmids\": [\"27320910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KDM4A histone demethylase controls HIF-1α levels by removing the repressive H3K9me3 mark at the HIF1A locus; KDM4A depletion or inactivation leads to H3K9me3 accumulation at the HIF1A gene, reducing HIF-1α mRNA and protein, and decreasing hypoxic tumor-aggressive phenotypes.\",\n      \"method\": \"KDM4A siRNA knockdown, ChIP (H3K9me3 at HIF1A locus), RT-qPCR, HIF-1α protein/mRNA levels, invasion/migration assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP at specific locus + functional knockdown, single lab\",\n      \"pmids\": [\"28894274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HIF1 binds to the PKM gene by chromatin immunoprecipitation and mediates an isoform switch from PKM1 to PKM2 after myocardial infarction, with coordinated upregulation of associated splicing factors (hnRNPA1, hnRNPA2B1, Ptbp1).\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) of HIF1 at PKM locus, RNA-seq, qRT-PCR, pyruvate kinase activity assays\",\n      \"journal\": \"Physiological genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional assays, single lab\",\n      \"pmids\": [\"29652636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF-1α transcriptionally upregulates p53 by binding to five response elements in the p53 promoter under hypoxia; this HIF-1α-induced p53 is transcriptionally inactive but acts as a chaperone protein for HIF-1α, stabilizing its binding to downstream DNA response elements and increasing HIF-1 target gene synthesis.\",\n      \"method\": \"Reporter assays, ChIP, Co-immunoprecipitation, siRNA knockdown of HIF-1α, normoxia/hypoxia comparison\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + reporter + co-IP with functional gene expression readout, single lab\",\n      \"pmids\": [\"31538203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF1A and NFAT5 coordinately boost antibacterial defense in macrophages under high-Na⁺ conditions: HIF1A-dependent autophagy induction and NFAT5-dependent autolysosomal targeting of intracellular E. coli are both required; this defense is independent of NOS2 and phagocyte oxidase.\",\n      \"method\": \"HIF1A siRNA/genetic knockdown, NFAT5 knockdown, autophagy flux assays, bacterial CFU assays, GSEA of transcriptome\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockdown of both factors with functional bacterial killing assay, single lab\",\n      \"pmids\": [\"30982460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HIF1a in oligodendrocyte progenitor cells (OPCs) activates non-canonical target genes (including Ascl2, Dlx3) through interaction with the OPC-specific transcription factor OLIG2; these non-canonical targets suppress Sox10 and block OPC differentiation into oligodendrocytes; MEK/ERK inhibition restores Sox10 expression without affecting canonical HIF1a activity.\",\n      \"method\": \"ChIP-seq in OPCs, OLIG2 co-IP, Ascl2/Dlx3 overexpression, Sox10 reporter assays, MEK/ERK inhibitor rescue, human oligocortical spheroids\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq + co-IP + genetic gain-of-function + pharmacological rescue in human organoids, multiple orthogonal methods\",\n      \"pmids\": [\"33091368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HIF-1α in cardiac fibroblasts (CFs) suppresses mitochondrial ROS to prevent excessive post-ischemic CF proliferation and scarring; CF-specific Hif-1a deletion increases mitochondrial ROS, excessive CF proliferation, and contractile dysfunction after MI; the mitochondrial-targeted antioxidant MitoTEMPO rescues Hif-1a mutant phenotypes.\",\n      \"method\": \"CF-specific Hif-1a knockout mice, MI model, scRNA-seq, 3D cardiac microtissues, MitoParaquat/MitoTEMPO pharmacological manipulation, ROS measurements\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple functional readouts + pharmacological rescue + 3D model, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"34762860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"m6A modification of Hif1a mRNA by FTO deficiency increases Hif1a mRNA translation via YTHDC2 recognition, elevating HIF1A protein; HIF1A then activates thermogenic gene transcription (Ppargc1a, Prdm16, Pparg), promoting white-to-beige adipocyte browning.\",\n      \"method\": \"FTO adipose-specific knockout mice, m6A-seq, RIP for YTHDC2, Hif1a KO rescue experiments, thermogenic gene expression, UCP1 assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO + m6A-seq + RIP + HIF1A KO epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"34569703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PADI4 directly interacts with and citrullinates HIF-1α at R698; this citrullination blocks VHL binding and prevents HIF-1α ubiquitination and proteasomal degradation, stabilizing HIF-1α; the PADI4 antagonist dihydroergotamine mesylate suppresses tumor progression.\",\n      \"method\": \"Co-immunoprecipitation, in vitro citrullination assay, mass spectrometry identification of citrullinated R698, VHL binding assay, ubiquitination assay, PADI4 inhibitor treatment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution + MS identification of PTM + mechanistic interaction assays + in vivo tumor model\",\n      \"pmids\": [\"39227578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Intermittent (rapid/cyclic) hypoxia increases HIF-1α protein via a distinct pathway involving KDM4A/KDM4B/KDM4C histone demethylases: intermittent hypoxia increases KDM4 activity, reduces H3K9me3 at the HIF1A locus, and increases HIF1A mRNA; this contrasts with chronic hypoxia, which decreases KDM4 activity and increases H3K9me3 globally and at the HIF1A locus.\",\n      \"method\": \"H3K9me3 ChIP at HIF1A locus, KDM4 activity assays, qRT-PCR, siRNA knockdown, comparison of intermittent vs chronic hypoxia protocols\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + KDM4 activity assay + siRNA, single lab but orthogonal methods\",\n      \"pmids\": [\"36174675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"STAT1 is a transcriptional suppressor of HIF1A: ATG7 deficiency upregulates STAT1 via an autophagy-independent pathway (through increased ZNF148 nuclear translocation), increased STAT1 binding to HIF1A promoter, and suppressed HIF1A expression, thereby impairing ischemia-induced angiogenesis.\",\n      \"method\": \"EC-specific Atg7 KO mice, ChIP (STAT1 at HIF1A promoter), co-immunoprecipitation (ATG7-ZNF148), HIF1A overexpression rescue, fludarabine STAT1 inhibition\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO + ChIP + co-IP + genetic rescue + pharmacological validation in vivo\",\n      \"pmids\": [\"36300763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP51 deubiquitinase directly binds Elongin C (ELOC) and forms a complex with the VHL E3 ligase to deubiquitinate HIF1A, stabilizing it; HIF1A in turn transcriptionally upregulates USP51, forming a positive feedback loop; SENP1-mediated deSUMOylation of ELOC at K32 promotes USP51–ELOC interaction and HIF1A stabilization.\",\n      \"method\": \"Co-immunoprecipitation (USP51/VHL/ELOC complex), ubiquitination assay, ChIP (HIF1A binding to USP51 promoter), SUMOylation site mutagenesis (ELOC K32), in vitro deubiquitination assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — deubiquitination reconstitution + complex co-IP + ChIP + mutagenesis of PTM site, multiple orthogonal methods\",\n      \"pmids\": [\"37816999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BAP1 deubiquitylase binds HIF-1α (through its C-terminal domain residues I675, F678, I679, L691), deubiquitylates it, and stabilizes HIF-1α during hypoxia; BAP1 mutations abolishing this interaction reduce nuclear HIF-1α in mesothelioma biopsies and primary cells.\",\n      \"method\": \"Co-immunoprecipitation, computational modeling of binding interface, BAP1 mutagenesis (I675A/F678A/I679A/L691A), siRNA BAP1 knockdown, HIF-1α protein level assays in hypoxia\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding + mutagenesis + deubiquitylation assay + clinical specimen validation\",\n      \"pmids\": [\"36656861\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HIF-1α is an O₂-regulated bHLH-PAS transcription factor that, under normoxia, is constitutively hydroxylated on Pro402/Pro564 by PHD2 (and related PHDs), enabling pVHL-mediated ubiquitination and proteasomal degradation, while asparagine-803 hydroxylation by FIH-1 blocks p300/CBP coactivator recruitment; under hypoxia both hydroxylation events are suppressed, allowing HIF-1α to heterodimerize with HIF-1β (ARNT), recruit coactivators including p300, TIP60, and PKM2, and directly bind hypoxia-response elements to transcriptionally activate hundreds of target genes controlling glycolysis, VEGF-driven angiogenesis, TWIST-mediated EMT, mitochondrial COX subunit switching, and immune cell fate; HIF-1α stability is additionally regulated by O₂-independent mechanisms including RACK1-mediated and HSP90-opposed ubiquitination, deubiquitination by BAP1 and USP51, citrullination at R698 by PADI4 (blocking VHL binding), mTOR-stimulated stabilization, and KDM4A/H3K9me3-mediated transcriptional control of the HIF1A locus.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HIF-1α is the oxygen-regulated subunit of the HIF-1 heterodimeric transcription factor that serves as a master regulator of cellular adaptation to hypoxia, controlling transcriptional programs for angiogenesis, glycolysis, cell survival, metastasis, and immune defense [PMID:13130303, PMID:19942427, PMID:30982460]. Under normoxia, PHD2-mediated hydroxylation of Pro402/564 promotes VHL E3 ubiquitin ligase binding and proteasomal degradation, while FIH-1-mediated hydroxylation of Asn803 blocks p300/CBP coactivator recruitment; under hypoxia, these hydroxylations are suppressed, allowing HIF-1α to accumulate, dimerize with HIF-1β, recruit coactivators including p300/CBP and the TIP60 complex, and bind HREs to activate target genes [PMID:17925579, PMID:16887934, PMID:27320910]. HIF-1α stability is further tuned by oxygen-independent mechanisms including RACK1-mediated ubiquitination competing with HSP90-dependent stabilization, deubiquitination by BAP1 and USP51, PADI4-mediated citrullination at R698 that blocks VHL binding, and epigenetic control of HIF1A transcription through KDM4A-dependent H3K9me3 demethylation and m6A-dependent translational regulation [PMID:17361105, PMID:36656861, PMID:37816999, PMID:39227578, PMID:28894274, PMID:34569703]. HIF-1α drives context-dependent gene programs by partnering with lineage-specific transcription factors such as OLIG2 in oligodendrocyte progenitors, directly activates TWIST to promote EMT and metastasis, and reprograms metabolism by inducing glycolytic enzymes and the PKM1-to-PKM2 isoform switch [PMID:33091368, PMID:18297062, PMID:29652636].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that HIF-1α requires HSP90 chaperoning for activation resolved how a constitutively synthesized protein is maintained in a signaling-competent state prior to hypoxic stabilization.\",\n      \"evidence\": \"Co-immunoprecipitation of HIF-1α with Hsp90, domain mapping, and geldanamycin inhibition in mammalian cells\",\n      \"pmids\": [\"10544245\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study without independent replication at the time\", \"Structural basis of Hsp90–PAS domain interaction not resolved\", \"Whether Hsp90 dissociation is actively regulated under hypoxia unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that calcium/calmodulin and the ERK pathway control HIF-1 transcriptional activity without affecting protein levels or DNA binding revealed a post-stabilization signaling layer that fine-tunes HIF-1 output.\",\n      \"evidence\": \"Pharmacological and dominant-negative interference with calcium/CaM/ERK signaling using HIF-1 reporter assays\",\n      \"pmids\": [\"12485909\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pharmacological study\", \"Direct phosphorylation targets on HIF-1α not identified\", \"Whether this pathway acts on coactivator recruitment not determined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining HIF-1 as a heterodimer of oxygen-regulated HIF-1α and constitutive HIF-1β that binds HREs to activate angiogenesis, glucose metabolism, survival, and invasion genes established the foundational framework for all subsequent mechanistic dissection.\",\n      \"evidence\": \"Transcriptional reporter assays, gene expression studies, and loss-of-function experiments across multiple systems\",\n      \"pmids\": [\"13130303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full catalog of direct HIF-1 target genes not yet defined\", \"Tissue-specific target gene selection mechanisms unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Biochemical reconstitution of the oxygen-dependent degradation pathway—prolyl hydroxylation, VHL recognition, ubiquitination, and proteasomal destruction—together with FIH-1-mediated asparagine hydroxylation blocking p300/CBP binding, established the dual oxygen-sensing mechanism governing HIF-1α stability and transactivation.\",\n      \"evidence\": \"Hydroxylation assays, mutagenesis of Pro402/564 and Asn803, VHL co-immunoprecipitation, ubiquitination assays, and reporter assays replicated across multiple labs\",\n      \"pmids\": [\"16887934\", \"17925579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of Pro402 vs Pro564 hydroxylation in different tissues not quantified\", \"How FIH-1 and PHD2 activities are differentially regulated at varying O2 tensions not fully resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovering that HIF-1α displaces Myc from Sp1 binding sites to repress mismatch repair genes (MSH2/MSH6) revealed a direct mechanism by which hypoxia promotes genetic instability, extending HIF-1α's role beyond transcriptional activation to active gene repression.\",\n      \"evidence\": \"ChIP, promoter reporters, co-immunoprecipitation, siRNA, and microsatellite instability analysis\",\n      \"pmids\": [\"15780936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HIF-1α–Sp1 repressive complexes operate at other Myc target genes not determined\", \"Contribution to clinical tumor mutational burden not causally established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying RACK1 as a competitor of HSP90 for PAS-A domain binding that recruits Elongin-C/B to promote O2/PHD/VHL-independent HIF-1α degradation established a parallel, oxygen-independent degradation axis.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, domain mapping, ubiquitination and proteasome inhibition assays\",\n      \"pmids\": [\"17361105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals controlling the HSP90/RACK1 balance not identified\", \"In vivo relevance of RACK1-mediated HIF-1α turnover not demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that HIF-1 directly activates TWIST transcription via HRE binding to drive EMT and metastasis, and separately activates laminin-332 to enable wound-induced keratinocyte migration, broadened HIF-1α's functional repertoire to cell motility and tissue repair beyond classical hypoxia responses.\",\n      \"evidence\": \"ChIP at TWIST and laminin-γ3 promoters, luciferase reporters, siRNA epistasis, in vivo metastasis and scratch-wound assays\",\n      \"pmids\": [\"18297062\", \"18713836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HIF-1α drives EMT through additional effectors besides TWIST not fully cataloged\", \"PI3K-dependent HIF-1α induction in wounding not mechanistically connected to prolyl hydroxylation status\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Comprehensive demonstration that HIF-1 directly transcribes glycolytic enzymes, glucose transporters, PDK1 (redirecting pyruvate from mitochondria), and BNIP3 (triggering mitophagy) unified HIF-1α's role as the central metabolic switch from oxidative phosphorylation to glycolysis in cancer.\",\n      \"evidence\": \"ChIP, reporter assays, gene expression and metabolic flux measurements in HIF-1α loss-of-function cells\",\n      \"pmids\": [\"19942427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each HIF-1 metabolic target to the Warburg effect not resolved\", \"How HIF-1α coordinates with HIF-2α in metabolic reprogramming remains incomplete\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing that TNFα/IKKβ signaling increases HIF-1α protein without affecting mRNA identified an inflammatory–hypoxic crosstalk pathway operating at the translational or post-translational level.\",\n      \"evidence\": \"IKKβ overexpression, knockdown, and KO MEFs with HIF-1α protein vs mRNA measurements and VEGF readout\",\n      \"pmids\": [\"19766100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Exact mechanism (translation vs stabilization) by which IKKβ increases HIF-1α protein not determined\", \"Whether IKKβ directly phosphorylates HIF-1α not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying the TIP60/KAT5 complex as a conserved HIF-1α coactivator required for chromatin modification and RNA Pol II activation at HIF target genes—but not for HIF-1α DNA binding itself—resolved how HIF-1α engages the transcriptional machinery after chromatin recruitment.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, ChIP, RNA-seq, and genetic knockdown in both Drosophila and human colorectal cancer cells\",\n      \"pmids\": [\"27320910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific histone marks deposited by TIP60 at HIF target loci not cataloged\", \"How TIP60 is recruited in a HIF-1α-dependent manner (direct or bridged) not structurally resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that KDM4A removes repressive H3K9me3 at the HIF1A locus to enable HIF1A transcription revealed an epigenetic layer controlling HIF-1α abundance upstream of protein stabilization.\",\n      \"evidence\": \"KDM4A knockdown/inhibition, H3K9me3 ChIP at HIF1A locus, qRT-PCR/Western blot, invasion assays\",\n      \"pmids\": [\"28894274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding\", \"Whether other KDM4 family members are redundant was not resolved until later studies\", \"Signals that regulate KDM4A activity at HIF1A specifically not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealing a HIF-1α–p53 positive feedback loop—where HIF-1α transcriptionally induces p53, which then chaperones HIF-1α at DNA—identified a mechanism amplifying HIF transcriptional output under sustained hypoxia.\",\n      \"evidence\": \"ChIP at p53 HREs, promoter reporters, co-immunoprecipitation, siRNA knockdown\",\n      \"pmids\": [\"31538203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"How transcriptionally inactive p53 chaperones HIF-1α structurally is not defined\", \"Relevance in p53-mutant tumors not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that HIF-1α partners with the lineage-specific transcription factor OLIG2 to activate non-canonical targets (Ascl2, Dlx3) that suppress Sox10 and block oligodendrocyte differentiation established that HIF-1α's transcriptional output is context-dependent and shaped by tissue-specific co-factors.\",\n      \"evidence\": \"ChIP-seq, RNA-seq, genetic HIF-1α accumulation in PSC-derived OPCs, OLIG2 co-immunoprecipitation, MEK/ERK inhibitor rescue\",\n      \"pmids\": [\"33091368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether OLIG2–HIF-1α interaction is direct or bridged not structurally defined\", \"Genome-wide catalog of OLIG2-dependent vs -independent HIF-1α targets incomplete\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing that m6A modification on HIF1A mRNA (regulated by FTO demethylase) is read by YTHDC2 to enhance translation established an epitranscriptomic control layer for HIF-1α protein abundance, independent of protein stabilization.\",\n      \"evidence\": \"m6A-seq, YTHDC2 RIP, adipose-specific FTO KO mice, polysome profiling, HIF1A ChIP at thermogenic gene promoters\",\n      \"pmids\": [\"34569703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific m6A sites on HIF1A mRNA not mapped at single-nucleotide resolution\", \"Whether YTHDC2-mediated translational control operates in non-adipose tissues not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extending the KDM4 findings, distinguishing that intermittent hypoxia activates KDM4A/B/C to demethylate H3K9me3 at HIF1A (increasing transcription) while chronic hypoxia suppresses these demethylases (reducing HIF1A mRNA) resolved how different hypoxia kinetics produce opposite HIF-1α responses at the chromatin level.\",\n      \"evidence\": \"H3K9me3 ChIP at HIF1A locus, KDM4 activity assays, gene expression under intermittent vs chronic hypoxia\",\n      \"pmids\": [\"36174675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Oxygen-sensing mechanism upstream of KDM4 activity not identified\", \"In vivo relevance in obstructive sleep apnea or tumor cycling hypoxia not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying that ATG7 sequesters ZNF148 in the cytoplasm to prevent STAT1-mediated transcriptional repression of HIF1A revealed an autophagy-independent, non-canonical function of ATG7 in maintaining HIF1A expression during ischemic angiogenesis.\",\n      \"evidence\": \"EC-specific Atg7 KO mice, STAT1 ChIP at HIF1A promoter, ZNF148–ATG7 co-IP, HIF1A overexpression rescue, fludarabine STAT1 inhibition\",\n      \"pmids\": [\"36300763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ZNF148 nuclear import activates STAT1 transcription not mechanistically resolved\", \"Whether this ATG7–ZNF148 axis operates beyond endothelial cells unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of two deubiquitinases—BAP1 and USP51—that stabilize HIF-1α through distinct mechanisms (BAP1 via direct N-terminal binding/deubiquitination; USP51 via Elongin C complex formation regulated by SENP1-mediated deSUMOylation) established that HIF-1α deubiquitination is an actively regulated, multi-enzyme process with positive feedback.\",\n      \"evidence\": \"Direct deubiquitination assays, co-immunoprecipitation of complex components, BAP1 alanine scanning mutagenesis, SUMO mutagenesis of ELOC, ChIP for HIF1A at USP51 promoter\",\n      \"pmids\": [\"36656861\", \"37816999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of BAP1 vs USP51 in different tissues or tumor types not compared\", \"Whether other DUBs contribute to HIF-1α stabilization not surveyed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that PADI4 citrullinates HIF-1α at R698 to block VHL binding and ubiquitination revealed a novel post-translational modification that stabilizes HIF-1α independently of prolyl hydroxylation status.\",\n      \"evidence\": \"Citrullination assay, R698 mutagenesis, VHL binding competition assay, ubiquitination assay, computational modeling\",\n      \"pmids\": [\"39227578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether citrullination at R698 is reversible and what enzyme would catalyze decitrullination is unknown\", \"Physiological stimuli that activate PADI4 toward HIF-1α not defined\", \"Interplay between R698 citrullination and nearby prolyl hydroxylation not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite detailed knowledge of individual regulatory inputs, an integrated quantitative model predicting HIF-1α protein levels from the combined activities of hydroxylation, ubiquitination, deubiquitination, citrullination, translational control, and chromatin-level transcription is lacking, as is a systematic understanding of how lineage-specific co-factors redirect HIF-1α to non-canonical targets across cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No systems-level model integrating all known HIF-1α regulatory inputs\", \"Tissue-specific HIF-1α transcriptional partner repertoire incompletely cataloged\", \"Structural basis for coactivator selectivity (p300/CBP vs TIP60) at different target genes not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 7, 8, 21, 22]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 7, 8, 10, 13, 21, 22, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4, 6, 7, 10, 13, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 6, 7, 8, 10, 13, 21, 22, 23]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 2, 3, 16, 17, 18]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [8, 20, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [19, 26, 27]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [25]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 2, 3, 16, 17, 18]}\n    ],\n    \"complexes\": [\n      \"HIF-1 (HIF-1α/HIF-1β heterodimer)\"\n    ],\n    \"partners\": [\n      \"ARNT\",\n      \"VHL\",\n      \"EP300\",\n      \"KAT5\",\n      \"BAP1\",\n      \"USP51\",\n      \"RACK1\",\n      \"HSP90AA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HIF-1α is the oxygen-regulated α subunit of the HIF-1 heterodimeric transcription factor that serves as a master regulator of cellular adaptation to hypoxia, controlling transcriptional programs for glycolysis, angiogenesis, epithelial–mesenchymal transition, immune cell differentiation, and mitochondrial remodeling [PMID:1448077, PMID:8089148, PMID:8756616, PMID:17418790, PMID:21871655]. Under normoxia, prolyl hydroxylase PHD2 hydroxylates Pro402/Pro564 within the oxygen-dependent degradation domain, enabling pVHL-mediated ubiquitination and proteasomal destruction, while FIH-1 hydroxylates Asn803 in the C-terminal transactivation domain to block p300/CBP coactivator recruitment; both hydroxylation events require Fe²⁺ and O₂ as cofactors and are suppressed under hypoxia, permitting HIF-1α stabilization, nuclear translocation, heterodimerization with ARNT (HIF-1β), and transcriptional activation at hypoxia-response elements [PMID:11292861, PMID:11292862, PMID:12912907, PMID:12080085, PMID:7539918]. HIF-1α stability is further tuned by O₂-independent mechanisms including RACK1-mediated Elongin-C/B ubiquitination competing with HSP90 chaperoning, PADI4 citrullination at R698 that blocks VHL binding, and deubiquitination by BAP1 and USP51 [PMID:17361105, PMID:39227578, PMID:36656861, PMID:37816999]. Beyond canonical hypoxia targets, HIF-1α cooperates with lineage-specific factors such as OLIG2 in oligodendrocyte progenitors and RORγt in T cells to activate context-dependent gene programs, and its transcription is itself regulated by KDM4A-mediated H3K9me3 demethylation at the HIF1A locus and STAT1-mediated repression [PMID:33091368, PMID:21871655, PMID:28894274, PMID:36300763].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of a hypoxia-inducible nuclear factor (HIF-1) that binds the erythropoietin enhancer established the existence of a dedicated transcriptional oxygen-sensing pathway.\",\n      \"evidence\": \"DNase I footprinting and EMSA with cycloheximide block in Hep3B cells\",\n      \"pmids\": [\"1448077\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of HIF-1 subunits unknown\", \"Mechanism of O₂-dependent induction undefined\", \"Generality beyond EPO gene not tested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Purification and cloning of HIF-1 as a bHLH-PAS heterodimer of HIF-1α and ARNT (HIF-1β) resolved its molecular architecture and showed both subunits contact DNA, while parallel work established HIF-1 as a general hypoxia mediator across cell types activating glycolytic and VEGF genes.\",\n      \"evidence\": \"Protein purification, UV cross-linking, cloning, EMSA/reporter assays in multiple cell lines and HRE mutagenesis\",\n      \"pmids\": [\"7539918\", \"7836384\", \"8387214\", \"8089148\", \"8756616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of O₂-dependent protein instability unknown\", \"No post-translational modification identified\", \"Coactivator recruitment mechanism undefined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the oxygen-dependent degradation (ODD) domain showed that a ~200 aa central region is both necessary and sufficient for O₂-regulated proteasomal degradation, narrowing the search for the oxygen-sensing modification.\",\n      \"evidence\": \"Systematic domain deletion and fusion-protein stability assays under normoxia/hypoxia\",\n      \"pmids\": [\"9653127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ligase targeting the ODD unknown\", \"Nature of the O₂-dependent modification undefined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that pVHL targets HIF-1α for O₂-dependent proteolysis provided the E3 ligase link, while HSP90 was identified as a normoxic chaperone of the bHLH-PAS domain required for HIF-1 competence.\",\n      \"evidence\": \"VHL re-expression rescue in VHL-null cells, co-IP, iron chelation; EGFP-HIF-1α co-IP and geldanamycin inhibition\",\n      \"pmids\": [\"10353251\", \"10544245\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of O₂-dependent VHL–HIF-1α binding unknown\", \"Nature of the iron-dependent signal unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The oxygen-sensing mechanism was resolved: prolyl hydroxylases (PHD/HPH) hydroxylate Pro564 (and Pro402) using O₂ and Fe²⁺ as cofactors, creating the pVHL-binding epitope; simultaneously FIH-1 was identified as a VHL-interacting protein that represses HIF-1α transactivation.\",\n      \"evidence\": \"Peptide binding assays, site-directed mutagenesis, mass spectrometry, in vitro hydroxylation reconstitution, RNAi in Drosophila, yeast two-hybrid and reporter assays for FIH-1\",\n      \"pmids\": [\"11292861\", \"11292862\", \"11598268\", \"11707426\", \"10878807\", \"11641274\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FIH-1 is also a hydroxylase not yet shown\", \"Relative contributions of PHD1/2/3 unresolved\", \"No structural model of hydroxylated HIF–VHL complex\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"FIH-1 was shown to be an asparaginyl hydroxylase modifying Asn803, which blocks p300/CBP recruitment; full HIF-1 activation requires abrogation of both prolyl and asparaginyl hydroxylation, establishing a dual oxygen-sensing checkpoint; mTOR was identified as an O₂-independent positive regulator acting through the ODD domain.\",\n      \"evidence\": \"In vitro hydroxylation with MS, Asn→Ala mutagenesis, p300 interaction assays; rapamycin inhibition with rapamycin-resistant mTOR rescue and ODD domain mapping\",\n      \"pmids\": [\"12080085\", \"11823643\", \"12242281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Asn-OH blocking p300 unknown\", \"mTOR mechanism on ODD not molecularly defined\", \"In vivo validation of dual checkpoint limited\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"PHD2 was identified as the critical prolyl hydroxylase setting normoxic HIF-1α levels, and HIF-1α was shown to specifically govern glycolytic gene expression (distinct from HIF-2α), establishing non-redundant target gene programs.\",\n      \"evidence\": \"Systematic siRNA knockdown of PHD1/2/3 in multiple human cell lines; DNA microarray comparison of HIF-1α−/− cells with regulated HIF-1α or HIF-2α re-expression\",\n      \"pmids\": [\"12912907\", \"14645546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PHD2 dominance holds in all tissues unknown\", \"Chromatin-level basis of target gene selectivity unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Succinate accumulation from SDH deficiency was shown to inhibit PHDs and stabilize HIF-1α, linking TCA cycle mutations to pseudo-hypoxic oncogenic signaling.\",\n      \"evidence\": \"SDH knockdown/inhibition with direct PHD activity assays and HIF-1α stability measurements\",\n      \"pmids\": [\"15652751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether fumarate acts similarly not yet addressed\", \"Quantitative kinetic parameters of metabolite-PHD inhibition undefined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"RACK1 was identified as a VHL/PHD-independent degradation pathway for HIF-1α, competing with HSP90 for the PAS-A domain and recruiting Elongin-C/B; separately, HIF-1 was shown to switch mitochondrial COX subunit composition (COX4-1→COX4-2) via LON protease induction, optimizing respiration at low O₂.\",\n      \"evidence\": \"RACK1 co-IP, domain competition, ubiquitination assay, siRNA; COX subunit ChIP, reporter, siRNA, metabolic flux and in vivo mouse model\",\n      \"pmids\": [\"17361105\", \"17418790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where RACK1 pathway dominates unclear\", \"Structural basis of RACK1–HSP90 competition undefined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"HIF-1α was shown to directly transactivate TWIST to drive EMT and metastasis, and to respond to non-hypoxic stimuli (mechanical wounding via PI3K), broadening the functional scope beyond classical hypoxia targets.\",\n      \"evidence\": \"ChIP at TWIST promoter, siRNA rescue of EMT; PI3K inhibition and scratch-wound assay with laminin-332 reporter\",\n      \"pmids\": [\"18297062\", \"18713836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TWIST is a direct or cooperative HIF-1α target in all cancer contexts unknown\", \"PI3K-HIF-1α stabilization mechanism not molecularly defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two major coactivator mechanisms were defined: PKM2 (itself hydroxylated by PHD3) acts as a HIF-1α coactivator enhancing p300 recruitment in a metabolic positive-feedback loop; HIF-1α drives TH17/Treg balance by activating RORγt while targeting Foxp3 for degradation, establishing HIF-1α as a lymphocyte fate regulator.\",\n      \"evidence\": \"PKM2 co-IP, ChIP, MS of hydroxylation, metabolic assays; T-cell-specific HIF-1α conditional KO mice, co-IP with Foxp3, EAE model\",\n      \"pmids\": [\"21620138\", \"21871655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKM2-HIF-1α axis operates in non-cancer tissues unclear\", \"Mechanism of HIF-1α-mediated Foxp3 proteasomal targeting not fully defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"TIP60 (KAT5) was identified as a conserved HIF-1α coactivator required for chromatin modification and RNA Pol II activation at HREs but dispensable for HIF-1α DNA binding, separating chromatin remodeling from target-site recognition.\",\n      \"evidence\": \"Co-IP, ChIP-seq, genetic knockdown in Drosophila and human cells, RNA Pol II ChIP\",\n      \"pmids\": [\"27320910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TIP60 is required at all HIF-1 target genes or a subset unknown\", \"Relationship between TIP60 and p300 coactivator functions not delineated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"HIF-1α was shown to activate non-canonical gene programs through interaction with lineage-specific transcription factors (OLIG2 in OPCs), suppressing Sox10 and blocking oligodendrocyte differentiation; MEK/ERK inhibition selectively reversed this non-canonical activity.\",\n      \"evidence\": \"ChIP-seq in OPCs, OLIG2 co-IP, gain-of-function, MEK inhibitor rescue, human oligocortical spheroids\",\n      \"pmids\": [\"33091368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other lineage-specific TF partners redirect HIF-1α in additional cell types is unexplored\", \"Structural basis of HIF-1α–OLIG2 interaction unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"O₂-independent regulatory inputs to HIF-1α were expanded: PADI4 citrullinates R698 to block VHL binding, KDM4A demethylates H3K9me3 at the HIF1A locus to control its transcription (with distinct dynamics under intermittent vs. chronic hypoxia), and STAT1 acts as a transcriptional repressor of HIF1A downstream of ATG7/ZNF148.\",\n      \"evidence\": \"In vitro citrullination with MS, VHL binding/ubiquitination assays; H3K9me3 ChIP at HIF1A locus under intermittent/chronic hypoxia; EC-specific Atg7 KO with STAT1 ChIP at HIF1A promoter and rescue experiments\",\n      \"pmids\": [\"39227578\", \"36174675\", \"28894274\", \"36300763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological triggers of PADI4-mediated citrullination of HIF-1α in vivo unknown\", \"How intermittent vs. chronic hypoxia differentially controls KDM4 activity mechanistically unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Two deubiquitinases were identified as direct HIF-1α stabilizers: BAP1 binds HIF-1α through defined C-terminal residues and its loss reduces nuclear HIF-1α in mesothelioma; USP51 forms a complex with VHL/Elongin-C to deubiquitinate HIF-1α, with SENP1-mediated deSUMOylation of Elongin-C promoting this interaction, creating a transcriptional positive-feedback loop.\",\n      \"evidence\": \"Co-IP, mutagenesis of BAP1 binding interface, deubiquitination assays, clinical mesothelioma validation; USP51–VHL–ELOC complex co-IP, ChIP of HIF-1α at USP51 promoter, ELOC K32 SUMOylation mutagenesis\",\n      \"pmids\": [\"36656861\", \"37816999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative quantitative contributions of BAP1 vs. USP51 to HIF-1α pool in different tissues unknown\", \"Whether BAP1 deubiquitination opposes VHL-specific ubiquitin chains or broader ubiquitin conjugates not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how lineage-specific transcription factor partnerships (beyond OLIG2 and RORγt) redirect HIF-1α target gene selection genome-wide; the structural basis of the RACK1–HSP90 competition at the PAS-A domain; quantitative integration of the multiple PHD-independent stabilization inputs (PADI4, BAP1, USP51, RACK1, mTOR) in physiological contexts; and whether intermittent versus chronic hypoxia engage fundamentally different HIF-1α regulatory circuits in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide chromatin accessibility basis for context-dependent HIF-1α target selection unknown\", \"No integrated quantitative model of competing stabilization/degradation signals\", \"In vivo validation of many O₂-independent regulatory mechanisms limited to single tissue models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 20, 26, 31, 34, 39]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 4, 5, 32, 34]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3, 46]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [34, 39]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 5, 20, 26, 31, 34, 39]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [6, 10, 11, 14, 19, 21, 33]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 20, 25, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 29, 44]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [31, 38]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7, 9, 10, 42, 45, 46]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 7, 23]}\n    ],\n    \"complexes\": [\n      \"HIF-1 (HIF-1α/ARNT heterodimer)\",\n      \"VHL-Elongin-C/B E3 ligase complex\"\n    ],\n    \"partners\": [\n      \"ARNT\",\n      \"VHL\",\n      \"EGLN1\",\n      \"HIF1AN\",\n      \"EP300\",\n      \"KAT5\",\n      \"PKM\",\n      \"BAP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}